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Laryngotracheal complex 
The patency of the larynx and the trachea is sometimes compromised acutely with a 
direct threat of suffocation or asphyxia. Of old this occurred quite often as a 
consequence of diphteria and other infectious diseases or as a result of various kinds 
of exogenous traumata. Infectious diseases for instance, epiglottitis are still among 
us but are usually handled efficiently by medication and occasionally by intubation. 
 
Figure 1.1. Sideview and coronalview of the larygotracheal complex (zakboek Keel-, Neus- en 
Oorheelkunde) 
Just anterior to the esophagus’ entrance, the larynx is positioned on top of the 
trachea. Its main biological function is protection of the airway for which it contains 
three structures, i.e. the epiglottis with the ary-epiglottic folds, the vestibular plicae 
(false cords) and the vocal plicae (vocal cords) (Figure 1.1). The only part of the 
laryngotracheal complex that forms a solid ring is the cricoid cartilage. This inferior 
part of the larynx sits on top of the tracheal rings which are C-shaped with a 
membrane at the posterior side. The cricoid stabilizes the larynx and a lot of muscles 
and ligaments are attached to it to facilitate for speech and swallowing. The cricoid 
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forms the subglottic area which is prone to trauma during intubation leading to 
mucosal damage and infection. 
This thesis focuses on the anatomy of the cricotracheal complex and on one of its 
most common pathology known as stenosis. The cricotracheal skeleton consists of 
hyaline cartilage, covered with a submucosal layer and mucosa that consists of 
ciliated, pseudostratified columnar epithelium (Figure 1.2A). The cells on top are 
ciliated, a specialization that allows particles and mucous to be displaced in the 
direction of the esophagus where particles are finally transported into the stomach. 
The tracheal epithelium is supported by loose connective tissue, called the lamina 
propria. It consists of cells with immune function (Figure 1.2B). The cartilaginous 
structures of the laryngeal skeleton and the trachea are interconnected by fibrous 
tissue, ligaments and muscles. These cartilaginous structures are important to keep 
the airway lumen open. The hyaline cartilage matrix has a firm consistency consisting 
for a large part of water that is retained by a network of collagen (mainly type II 
collagen) and glycosaminoglycans. The cartilage itself contains no blood vessels but  
is covered externally by the perichondrium that accomodates the nutritional 
vascularisation.  
 
  
Figure 1.2. Cross-section of human trachea (H & E). A) Magnification (original x10) with submucosa 
and respiratory epithelium. B) Magnification (original x40) shows the different layers of the epithelium 
and cartilage (see page 113 for color figure). 
In any ENT-department, patients present occasionally with chronic problems 
associated with decreased patency of the laryngotracheal part of the airway. This 
anomaly, known as stenosis, sometimes makes an operative procedure necessary 
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which basically consist of resection of the stenotic part of the laryngotracheal airway 
and reconstruction of the remaining upper and lower ends to restore its continuity. 
Stenosis develops if the mucosa gets injured between the tube and the cricoid 
cartilage ring during intubation or in prolonged intubation. This leads to ulceration and 
granulation tissue with scar formation and stenosis. For some of these patients, the 
airway can be reconstructed by an end-to-end anastomosis of the rest of the larynx 
and the trachea. If the length of the stenotic segment is too long for this option, then 
a lengthwise incision of the stenotic segment and expansion of the cross-section with 
autologous cartilage is a viable alternative. 
Other categories of patients would include victims of exogenous or endogenous 
trauma (for instance due to the inhalation of hot gases), benign or malignant tumours 
and patients with re-stenosis after earlier attempts of reconstruction. The treatment 
for these patients is resection of the damaged parts of the cricotracheal complex and 
reconstruction. For some defects, tissue from elsewhere in the body is necessary to 
rebuild the cricotracheal complex.  
In this thesis we evaluated cartilage integration and the survival of cartilage grafts 
over time after laryngotracheal reconstruction in chronic laryngotracheal stenosis. In 
order to find new ways to improve laryngotracheal reconstructions in the future we 
have employed the biomaterial titanium in a series of animal experiments in 
combination with a vascular carrier and mucosal autografts. 
 
Laryngotracheal stenosis (LTS)  
LTS is an infrequent but challenging problem of the airway. Causes of LTS are the 
sequelae of local tumours, infection and trauma especially those caused by 
intubation1. Nearly 10% of intubated adult patients will subsequently develop LTS2. 
Although the risk increases with prolonged intubation, subglottic injury has been 
demonstrated within hours after intubation especially the traumatic variant and after 
tracheotomy. LTS in children is a special problem. Children’s stenosis may be 
congenital (0.3-1%) but are usually acquired (>90%)3. Today, more children require 
intubation and ventilation for extended periods of time following extensive surgery or 
major trauma. Premature infants are the ones particularly at risk. Between 1 and 9% 
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of all these intubated pediatric patients will develop a stenosis4-10. Prolonged 
endotracheal intubation or traumatic intubation can cause injury of the mucosal lining 
leading to ulceration, granulation, cartilage necrosis and scar tissue formation leading 
eventually to LTS4-7. 
Patients with LTS present with inspiratory stridor or dyspnea. The diagnosis is made 
by a laryngotracheoscopy. This should be done preferably in a spontaneously 
breathing patient to determine the vocal cord movement, the exact location, the 
extent and the nature of the stenosis and to exclude other causes of dyspnea. Its 
severity (degree of narrowing) is graded on the Myer-Cotton scale11, based on the 
percentage of obstruction; grade I from normal to 50% of the surface; grade II from 
51% to 70%; grade III from 71% to 99%; grade IV for no detectable lumen. 
Furthermore if resection is being considered, one should take into consideration the 
amount of space beneath the glottis for end-to-end anastomosis, the length of the 
stenosis to be resected and the function of the vocal cords. 
Surgical repair of LTS is a challenging aspect of airway management. The principle 
of subglottic resection in infants and children is basically identical to that of adults 
although a child’s airway is smaller and the postoperative management more difficult. 
For subglottic and short segment stenosis, repair can be achieved by making use of 
cartilage interposition grafts in cricotracheal split procedures and with cricotracheal 
resection (CTR) followed by end-to-end anastomosis12,13. The Sophia Children's 
Hospital has been a major referral center for children with laryngeal stenosis since 
the 1970's. At present a single stage laryngotracheal reconstruction (SS-LTR) or 
CTR is usually performed in most cases14-18. SS-LTR is an open reconstruction of the 
airway using cartilage grafts placed in anteriorly and posteriorly split cricoid. The 
indications for SS-LTR are grade I and II stenosis and grade III stenosis with glottic 
involvement. In patients with grade IV stenosis or grade III with enough space 
between the vocal cords and the stenosis, a CTR is indicated19.  
In chapter 2 we studied the integration of cartilage in laryngotracheal reconstruction 
in pediatric patients operated on in the last thirteen years using the SS-LTR 
technique at the Sophia Children's Hospital in Rotterdam, the Netherlands.  
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In chapter 3 we analysed the cartilage-cartilage integration after laryngotracheal 
reconstruction in time. In three patients we performed a MRI of the laryngotracheal 
complex to learn the fate of the cartilage grafts over time by comparing the 
postoperative MRI-images 3, 6 and 11.5 years after.  
 
Laryngotracheal defects 
Resection of the trachea theoretically can be done safely after resection of up to one-
half of the trachea in adults and one-third in infants and small children. The incidence 
of these cases is not known but most Ear Nose Throat-clinics performing tracheal 
surgeries see a few such patients annually. 
The problem with cartilage when used to reconstruct part of the airway is its 
integration within the surrounding tissues. Ideally an autologous cartilage graft should 
integrate with the adjacent cartilage of the trachea or cricoid. However cartilage 
possesses a poor intrinsic repair capacity. Both in vivo and in vitro studies have 
shown chondrocyte death in cartilage wound edges20-23. This leads to the formation 
of an acellular band leaving avital tissue in the area where integrative cartilage repair 
is required. Several enzymatic digestions have been used in an experimental setting 
in order to increase the initial adhesion of cells or cartilage tissue to host cartilage 
wound edges24-26. Previously we have shown that treatment of an explant with 
collagenase for 48 hours restored the number of vital chondrocytes in the lesion back 
to normal values after 14 days of culture22. 
The purpose of the study in chapter 4 is to shorten the collagenase enzyme 
treatment period thereby increasing its potential clinical application. We tested the 
effect of treatment of the graft with (a combination of) hyaluronidase and collagenase 
in various concentrations and for various periods of time (down to 1 hour). 
Parameters used were the number of viable cells in the wound edges during culture 
follow-up in an athymic mice model. 
Long segment stenosis involving more than half of the entire tracheal length and re-
stenosis after an initial resection and end-to-end anastomosis remains a therapeutic 
problem since resection of extra tracheal tissue is (usually) not possible. For such 
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cases, augmentation of the stenotic segment using repair tissues is a valuable 
option.  
Ideally, a tissue for laryngotracheal reconstruction would consist of viable cartilage 
and respiratory mucosal lining similar to that of the original trachea. Unfortunately 
there is no such composite tissue elsewhere in the body that meets these 
requirements. Most of the reconstructive tissues applied clinically lack one or both 
components leading to a large variation in results. Delaere et al.27 created a 
prefabricated and prelaminated repair tissue composed of revascularized elastic ear 
cartilage with buccal mucosal lining and applied it clinically with satisfactory results. A 
major drawback of this technique is the long waiting period that is necessary to allow 
revascularisation of the mucosa and remucosalization of the cartilage graft, before 
the whole regenerated tissue can be finally transferred to the neck area. Cartilage, by 
nature is avascular and possesses anti-angiogenic properties, making it a less 
suitable support tissue for mucosal grafts. This was clearly shown by Delaere et al.28, 
when they reconstructed circumferential tracheal defects in rabbits with tubed 
auricular cartilage pre-wrapped in vascularized fascia. Despite the improvement of 
vascularisation around the tube, healing through remucosalization only occurred 
around the anastomotic regions leaving the central portions of the grafts bare and 
partially necrotic. 
The limitations of composite autologous tissues such as cartilage and mucosa 
stimulated the introduction of various biomaterials. Experiments with solid titanium, 
Medpor, hydroxyapatite29-31 or tissue-engineered cartilage with chondrocytes seeded 
in polypropylene or polyglycolic acid with or without mucosal lining 32-34 have been 
performed. The main problem in these studies was the regeneration of the mucosal 
lining, as reviewed by Tan et al.35. In cases of minor defects, reepithelialization from 
the wound edges occurred, but for larger defects this process of reepithelialization 
proved to be insufficient. A possible solution to this problem is the use of stable 
porous biomaterials which allow for the ingrowth of new bloodvessels through their 
pores which revascularizes the implanted mucosal component and thereby ensure its 
survival. Any biomaterial used for this purpose should be strong enough to keep the 
airway lumen open and should not evoke a foreign body reaction or inflammation.  
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In chapter 5 we investigated if human and rabbit buccal mucosa will survive on 
porous titanium in an athymic mice model and in a rabbit laryngotracheal 
reconstruction model. The specific objective of the first part of the study is to 
determine if angiogenesis occurs through the porous titanium, allowing graft survival 
in comparison with cartilage grafts. The specific objective in the second part is to 
analyze if a construct of porous titanium and buccal mucosa is well tolerated inside 
the trachea of a living rabbit. 
In chapter 6 full-thickness laryngotracheal defects (cartilage and mucosa) were 
created and reconstructed with porous titanium in combination with autologous 
tissues in four different ways in an animal model. The question was if vascular 
carriers are really necessary when porous titanium is used for reconstruction. 
Specific questions were; (1) is a fascia flap really needed as a vascular supply, (2) is 
a two-stage operation needed, the first stage to implant the titanium in order to allow 
bloodvessels to grow through it and the second stage to implant the titanium with the 
fascia into the defect, (3) is a mucosal graft really needed to close a defect? 
The overall aim of this thesis is to improve laryngotracheal reconstruction by split-
procedures and cartilage graft integration. In addition we tested the feasibility of 
porous titanium with or without a vascular carrier and a mucosal graft as a substitute 
for cartilage grafts. 
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Abstract 
Introduction. Laryngotracheal stenosis (LTS) in children can be treated with single 
stage laryngotracheal reconstruction (SS-LTR) with cartilage grafting. The objective 
of this study was to evaluate the surgical outcome of SS-LTR during 13 years, and to 
find an optimum duration of the direct postoperative intubation period. 
Patients and methods. In a retrospective study, the surgical records and 
postoperative course of 60 children, who underwent SS-LTR in the period January 
1994 until December 2006, were analyzed. All patients underwent anterior or anterior 
and posterior cricoid split and anterior proximal tracheal split with insertion of 
cartilage grafts performed by the second author. Median age at time of operation, 
median number of days intubated and median days of hospital stay were recorded. 
Outcome of surgery was expressed in terms of decannulation rate, stridor, and 
quality of voice.  
Results. A total of 60 children underwent a SS-LTR. Fifty-six patients were diagnosed 
with an acquired, and four with a congenital stenosis. Forty patients had a grade III 
stenosis, 17 a grade II, three a grade I. No patient had a grade IV stenosis. The 
median age at surgery was 2.0 year (0.6-15.8 year). The median time of 
postoperative intubation was four days with a minimum of one and a maximum of 26. 
The median stay in the hospital was 13 days (4-103). In 57 patients a sufficient 
laryngeal lumen was attained. Three patients could not permanently be extubated 
and still have a tracheostomy. Of the 57 patients without a tracheostomy 51 (89.5%) 
had no stridor, three (5.3%) had stridor on exertion and three (5.3%) had stridor at 
rest. The voice was reported by the parents as normal in 35 (61.4%) patients. 
Twenty-two patients (38.6%) had a hoarse voice. The mean follow-up was almost 2 
years with a range of 6 months to 12.6 years. 
Conclusion. SS-LTR leads to decanulation in most cases of LTS in children. The 
majority of patients were successfully extubated after 2-3 days. 
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Introduction 
Laryngotracheal stenosis (LTS) in children is one of the most challenging problems 
that affect the airway. The stenosis can be congenital (0.3-1% of reported cases) but 
is usually acquired (>90% of reported cases)1. Between 1 and 9% of all intubated 
pediatric patients who are intubated for more than 24 hours will develop a stenosis2-8. 
Prolonged endotracheal intubation can cause mucosal necrosis leading to ulceration, 
granulation, scar tissue formation and eventually laryngeal stenosis4-6,8. Particularly 
at risk are premature infants on prolonged ventilatory support and children requiring 
intubation and ventilation for an extended period following extensive surgery or major 
trauma.  
The Sophia Children's Hospital, a tertiary university referral center in the Netherlands 
has been treating laryngeal stenosis in children since the 1970's. Several methods 
have been used in the past. In the earlier days the preferred method was dilatation 
and intubation. This was later abandoned in favor of the later two stage 
laryngotracheal reconstruction and stenting. At present laryngeal stenosis are mainly 
treated with single stage laryngotracheal reconstruction (SS-LTR) or cricotracheal 
resection (CTR)9-13. SS-LTR is an open reconstruction of the airway using cartilage 
grafts placed anteriorly and posteriorly after a cricoid split. The success rate of this 
type of surgery is satisfactory but depends on many factors like proper selection of 
patients, preoperative screenings, patient related factors, type of pathology, timing of 
surgery and standard of care in the postoperative period. 
The aim of this study is review our experience in the management of LTS in children 
over the last thirteen years and present the surgical outcomes of SS-LTR at the 
Sophia Children's Hospital in Rotterdam, the Netherlands. Described are the 
patients, the pre-operative work-up, the surgical and postoperative procedures and 
the follow-up period. An important aspect was the duration of the postoperative 
intubation period. 
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Materials and methods 
Patients. The medical records of all children (n=60) who underwent SS-LTR due to 
an acquired or congenital laryngeal stenosis at the Sophia Children's Hospital in 
Rotterdam, the Netherlands between January 1st  1994 and 31 December 2006. The 
chart review included patient data concerning medical history, laryngoscopic findings, 
tracheotomy, age at surgery, grade of stenosis at the time of surgery, days of 
postoperative intubation, length of hospital stay, follow-up laryngoscopies and 
complications.  
Pre-operative management. Laryngotracheoscopy in a spontaneously breathing 
patient was performed to locate the stenosis and to exclude other causes of airway 
obstruction. The presence of any sign of infection and the degree of inflammatory 
change were noted. The degree of narrowing was graded on the Myer-Cotton 
scale14, on the basis of the percentage of obstruction: grade I to 50% of the surface; 
grade II from 51% to 70%; grade III from 71% to 99% (any detectable lumen); grade 
IV total obstruction. Furthermore, the location in reference to the subglottic space 
(adequate space beneath the glottis for end-to-end anastomosis) and length of the 
stenosis was noted. In the same session, the function of the vocal cords was 
assessed. The indications for SS-LTR were grade I and II stenosis and grade III 
stenosis with glottic involvement. In patients with grade IV stenosis or grade III with 
enough space between the vocal cords and the stenosis a CTR was performed15. All 
patients were screened for signs of reflux during the endoscopy. Symptoms of reflux 
are regurgitation, red arytenoids and pachydermia of the inter-arytenoid region. In 
some patients 24 hour pH metry was performed to exclude a pathological reflux. A 
pathological reflux was treated with omeprazole or when necessary with 
fundoplication according to Nissen. All patients were given prophylactic omeprazole 
to keep the mucosa in the best possible condition as well before as after the 
operation.  
Operative technique. Cartilage grafts were harvested from one of the most caudal 
costal ribs. Surgical exposure included a horizontal cervical incision with excision of 
the tracheostomy. The laryngeal skeleton was freed anteriorly and bilaterally. A 
vertical incision was made through the anterior wall of the cricoid and two to three 
proximal tracheal rings. The cricoid cartilage was split posteriorly down to the 
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hypopharynx muscular layer exept for three patients with grade III stenoses. The 
costal cartilage was molded to fit in the posterior split with the perichondrium facing 
the luminal side. The patient was re-intubated nasotracheally with a tube that just fits 
the lumen. This tube is used for 4 days as a stent. Another costal cartilage graft was 
placed anteriorly with the perichondrium facing the lumen exept for seven patients; 
they only had a postior graft11. 
Post-operative management. All children were admitted to the pediatric intensive 
care unit postoperatively. Prophylactic antibiotics (cefuroxim) were given for 7 days 
followed by co-trimoxazol in a prophylactic dosis for 6 weeks. All patients received 
anti-reflux medication until 6 weeks after the last extubation. Patients received enteral 
nutrition through a transpyloric tube. In the first few years the children were paralyzed 
and heavily sedated with muscle paralyzers. In the later years, the use of muscle 
paralysis was abandoned and the patients were sedated with midazolam. The 
patients were preferably not ventilated, and the intubation time could be shortened to 
3-4 days.  
Laryngotracheoscopy was done 3-4 days after surgery, immediately followed by 
extubation in most cases. All children received two doses of dexamethasone (0.5 
mg/kg, 6 h apart) prior to extubation.  
Immediate post extubation stridor was treated with extra oxygen, inhalational steroids 
and/or epinephrine. When this proved to be insufficient an endoscopy was performed 
and if necessary a controlled re-intubation by the ENT-specialist.  
When there is a sufficient lumen after extubation patients were observed for some 
days at the nursing department and were discharged when the airway remained 
stable. 
Follow up. Patients were seen at the out-patient clinic 2-4 months after surgery. 
Stridor was graded as; no stridor at all, stridor during exercise and stridor at rest. The 
quality of the voice was evaluated by the parents and the physician as normal or with 
any form of hoarseness or roughness. No objective voice quality tests were obtained. 
Some patients with voice disorder were seen by our foniatrician and speech 
pathologist for further guidance. 
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All patients underwent routinely flexible endoscopy when possible. When there were 
signs of granulation tissue with stridor or dyspneua endoscopy under general 
anaesthesia was performed. We did not performed routine endoscopies under 
general anaesthesia except for the first one after 4 days due to ethical reasons. Only 
on indication this was performed. 
 
Results 
A total of 60 children underwent a SS-LTR. In 56 children (93.3%), stenosis was due 
to intubation injury. A congenital laryngeal stenosis was present in four children 
(6.7%). Table 2.1 outlines the general patient characteristics and table 2.2 outlines 
the co-morbidities of the patients. Median age at reconstruction was 2 years; the 
youngest child was 7 months and the oldest almost 16 years of age. Forty patients 
(66.7%) had a grade III stenosis 17 (28.3%) a grade II and three (5.0%) a grade I. 
There were no patients with grade IV. Forty patients had normal vocal cord 
movement, six suffered from less movement of one or both vocal cords and in 14 
patients the vocal cords were fixated. Fifty-seven patients underwent anterior and 
posterior split, of these, 50 patients got as well an anterior as a posterior graft and 
seven patients only got a posterior graft. Three patients had an anterior split with 
anterior graft. 
The median time of postoperative intubation was 4 days with a minimum of 1day and 
a maximum of 26 days (Figure 2.1). The median post-operative stay in the hospital 
was 13 days with a minimum of 4 days and a maximum of 103 days. In 57 patients a 
sufficient laryngeal lumen was attained. This was defined as breathing without stridor 
at rest. 
22 
 
Figure 2.1. Days of intubation (X-axis) and number of patients (Y-axis). Notice that most patients were 
extubated on day three, four or five (37 patients, 62%). 
 
Median age (months) at time of surgery 23,5 (7-188) 
Male / female 26 / 34 (43%/57%)
Intubation injury 56 (93%) 
Congenital laryngeal stenosis 4 (7%) 
Tracheotomy before operation 47 (78%) 
Anterior and posterior split 57 (95%) 
Anterior split with anterior graft 3 (5%) 
Anterior and posterior graft 50 (83%) 
Posterior graft 7 (12%) 
Grade I (Myer-Cotton scale) 3 (5%) 
Grade II (Myer-Cotton scale) 17 (28%) 
Grade III (Myer-Cotton scale) 40 (67%) 
Grade IV (Myer-Cotton scale) 0 (0%) 
Median days of intubation after operation 4 (range 1-26) 
Median days in hospital 13 (range 4-103) 
Re-intubation 9 (15%) 
Re-tracheotomy 3 (5%) 
Table 2.1. Patient characteristics (n=60)  
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Re-intubation. Nine patients (15%) needed re-intubation after the first extubation. The 
reasons were granulation tissue (five patients), oedema (two patients) and dyspnoea 
without any visible disorder (two patients). Three patients (5.0%) eventually needed a 
tracheotomy because of dyspnoea. These three patients all had a grade III stenosis, 
one with vocal cord pareses, two with normal vocal cord movement. The other six 
patients (10%) were finally extubated after various periods of time. Four of these six 
patients had a grade III stenosis, one patient with vocal cord pareses and two with 
vocal cord fixation. The other two of these six patients had a grade II stenosis with 
normal vocal cord mobility. 
Prematures 27 
Down syndrome 6 
Cardiac disease/anomalities 6 
Respiratory syncytial virus 4 
Trauma 3 
Pseudo-croup 4 
CHARGE association 1 
Pierre Robin sequence 1 
Craniolsynostosis 1 
Omphalocele/encephalocele 2 
Beck-Wiedemann syndrome 1 
Esophageal atresia 1 
VATER association 1 
Multiple dysmorphisms 1 
Partial situs inversus 1 
Lobectomy 1 
Subglottic haemangioma 1 
Kawasaki disease 1 
Retardation 1 
Hyaline membrane disease 1 
Table 2.2. Patient co-morbidities 
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Last out-patient visit. The median follow-up was more than 2 years with a range from 
6 months till 12.5 years. Of the 57 decannulated patients 51 (89.5%) had no stridor, 
three (5.3%) had stridor on exertion and three (5.3%) had stridor at rest. The voice 
was normal in 35 (61.4%) patients. Twenty-two patients (38.6%) suffered from 
hoarseness or roughness. Of these patients eight had vocal cord pareses or fixation 
before the operation. 
 
Discussion 
Laryngeal stenosis is one of the most challenging aspects of airway management. 
There is no single reconstructive technique that can solve all benign stenotic defects 
of the airway. The choice of the surgical procedure depends on the severity, location 
and length of the stenosis, as well as the preference and experience of the surgeon. 
Although the most severe stenosis are treated with laryngotracheal reconstruction 
with cartilage graft insertion or CTR and end-to-end anastomosis, there are some 
minimally invasive techniques available for the mild stenoses (grade I and II), such as 
laser surgery and balloon laryngoplasty. Laser is used in the management of anterior 
and posterior glottis webbing with the CO2-laser being most frequently used16. 
Another endoscopic technique is the balloon laryngoplasty to dilate the subglottic 
stenosis17. These treatments can be combined with the local application of Mitomycin 
C to prevent post-treatment scar formation18. 
Laryngotracheal reconstructions are indicated in less severe stenosis and posterior 
transglottic stenosis. The goal is to create a larger lumen which can be achieved by 
expanding the stenosis after anterior and posterior split. In the past, these techniques 
involve placement of intraluminal stents. In SS-LTR the only ‘’stenting’’ is the 
temporary use of an endotracheal tube11,19. The cartilage grafts keep the expanded 
cricoid and trachea open. CTR is indicated for cases of severe subgottic stenosis 
(grade III and IV). In this operation the stenotic segment is removed and the trachea 
is anastomosed to the subglottic space. In stenosis without residual subglottic space 
we think that a SS-LTR is the better option. Many different opinions exist about which 
technique should be used for which case as reviewed by Bailey et al. in 200215. 
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Of all 60 patients in our study group 57 (95%) had a sufficient laryngeal lumen at 
discharge. This high success rate is due to several factors. In our department we 
strictly adhere to a standardized work-up and follow-up for all of our patients. 
A laryngotracheoscopy is only performed by an experienced otolaryngologist. The 
degree of maturation of the scar tissue is always evaluated and the operation is 
performed only when the stenosis is mature and there were no signs of inflammation 
(redness, oedema and granulation). Strict adherence to this rule had contributed to 
our good results. 
Other causes of upper airway obstruction which sometimes could have possibly been 
the initial reason for intubation, such as a narrow nose, narrow choanal region, 
retrognathia, macroglossia, vocal cord dysfunction, supratracheostomal collapse, or 
tracheomalacia when noted, should always be dealt with prior to the SS-LTR20. 
The median intubation duration after laryngotracheoplasty in this study was 4 days 
although shorter intubations appeared to be sufficient. One single patient who 
extubated himself accidentally on the first postoperative day, was not re-intubated 
and recovered well. The same holds for the patients extubated after 2(two patients) 
and 3(seven patients) days. This suggests that it is possible to limit intubation to 3 or 
even 2 days. 
As a matter of course a high-level intensive care unit allowing for necessary optimal 
care immediately after the operation up to the phase of early extubation is critical for 
success of the treatment. To avoid unnecessary re-intubation with the chance of 
damaging the reconstruction, a multidisciplinary approach and a proper 
communication between the otorhinolaryngologist and intensive care specialist and 
nursing staff are a must. 
In our series there were no fatalities. Nine patients needed re-intubation because of 
granulation tissue(five patients), oedema(two patients) or dyspnoea(two patients) 
without manifest anatomical disorders. Three patients (5.0%) eventually needed a 
new tracheotomy because the laryngeal obstruction, did not respond to conservative 
measures or re-intubation. 
At the last follow up visit 51(85%) of the patients had no stridor at all. One-third of all 
patients had voice disorders. As the primary goal of laryngotracheal surgery is to 
create a sufficiently patent airway it is only in the course of the last few years that 
more attention has been paid to voice outcome. Baker and Kelcher21,22 stress that 
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more attention should be paid to voice impairment scales after laryngotracheal 
reconstructions. 
Comparing the results of various treatments is difficult, due to ill defined criteria of 
success. In many studies decannulation has been the main parameter of success. 
Others define success based on functional outcome, i.e. dyspnoea and phonation. 
Cotton reported an 86% success rate for SS-LTR in his study in 199223 and a 
decannulation rate of 90% for all techniques used in another review24. Lusk had one 
failure out of 19 patients in his first series of SS-LTR in 199119. Seid had 12 
successful extubations after SS-LTR out of 13 patients11. Triglia in Marseille reported 
95% decannulation rate in 98 children who were operated with different techniques 
including 58 laryngotracheal reconstructions25. The decannulation rate of 95% in our 
study is comparable with the decannulation rates found in literature after SS-LTR or 
CTR26-29. 
 
Conclusion 
Our results compare well with those of other centers in terms of decannulation rate. 
SS-LTR led to decannulation in most children with laryngeal stenosis. SS-LTR 
appears to be an effective and safe operation in selected cases of LTS in children. 
Furthermore, our series suggest that intubation time after the operation can be as 
short as 2 or 3 days. 
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Abstract 
MRI of cartilage grafts used in three children who were treated with single stage 
laryngotracheal reconstruction (SS-LTR) for laryngotracheal stenosis was performed 
respectively 3, 6 and 11.5 years after the initial operation. The indication for MRI was 
airway obstruction with suspicion of displacement of the cartilage grafts. In all three 
patients the grafts were visible on MRI. There was no cartilage-cartilage connection 
or fusion, but the cartilage grafts were connected to the surrounding structures with 
what we believe is fibrous tissue. No signs of resorption were seen. 
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Introduction 
At the Sophia Children's Hospital, a tertiary university referral center, the majority of 
patients with laryngotracheal stenosis (LTS) are treated with single stage 
laryngotracheal reconstruction (SS-LTR), an one-stage open reconstruction of the 
airway with anterior and posterior cricoid split and insertion of autologous costal 
cartilage grafts to expand the lumen.  
Cartilage is an avascular structure and when harvesting a piece of cartilage 
chondrocytes will die in the wound edges. This leads to the formation of an acellular 
band with avital tissue with no potention to heal adequately1. The cartilage will be 
connected with fibrous tissue to surrounding structures. Zalzal studied autologous 
cartilage graft survival in rabbits in 19862. He found 100% graft survival with 
autologous elastic cartilage. An important factor in survival of the cartilage could be 
the perichondrium. In our operation technique the cartilage is used with the 
perichondrium facing the lumen of the larynx and trachea. The posterior graft is 
positioned between the cricoid halves and covered with fibrin glue. The anterior 
cartilage graft is stitched to the incision edges. Imaging of cartilage with MR is not 
extensively described yet in the pediatric literature. MR imaging with high resolution 
gadolinium enhanced T1-weighted spin echo sequence of tracheal cartilage grafts in 
rabbits was shown by Delaere et al. in 19993. In our study we used an MRI technique 
with special surface coils to give a high resolution of the cricotracheal complex to 
make the cartilage visible. 
The aim of our case-study is to examine the fate of the cartilage grafts after various 
periods of time: are signs of resorption present? And how does the graft integrate 
with the surrounding tissue? 
 
Patients  
Patient I. A boy with a congenital stenosis grade III according to Myer-Cotton4 and 
Kawasaki’s disease underwent a tracheotomy at the age of 3 months. One year later 
a SS-LTR was performed with an anterior and posterior split and grafting. The 
postoperative period was complicated by severe airway obstruction caused by 
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granulation tissue, displacement of the anterior graft, and collapse of the anterior 
tracheal wall. A tracheostomy was necessary 3 weeks after the operation. MRI was 
performed 3 years after the operation (Figure 3.1)  
 
 
Figure 3.1. This axial T1 weighted image shows the larynx. The anterior graft is more intense 
compared to the cricoid (white arrows). At this more proximal level the anterior graft was in place.  
 
  
Figure 3.2. These axial T1 weighted (A) and T2 weighted (B) image shows a larynx 6 years after the 
SS-LTR with anterior and posterior cartilage grafts. The small arrow is pointing at the anterior split, just 
above the level of the anterior graft which is not visible in this image. The bigger arrow is pointing at 
the posterior graft which is displaced a little into the laryngeal lumen. 
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Patient II. A 13.5 years old girl underwent SS-LTR for a posterior glottic and 
subglottic grade II stenosis following prolonged intubation and ventilation after her 
premature birth. She had no tracheostomy, but moderate symptoms of airway 
obstruction. During the years after the operation stridor re-occurred. A MRI was 
performed 6 years after the SS-LTR (Figure 3.2). 
Patient III. A girl with Down syndrome and a subglottic stenosis grade III caused by 
prolonged intubation and ventilation underwent SS-LTR at the age of 22 months. The 
cricoid was split anteriorly and posteriorly with a mucosal graft posteriorly and a 
cartilage graft anteriorly. Over the years several endoscopies were performed 
because of signs of airway obstruction caused by a mild rest stenosis. A MRI was 
performed 11.5 years after the operation to see how the cartilage graft was situated 
in the cricotracheal complex (Figure 3.3). 
  
Figure 3.3. These axial T1 weighted (A) and T2 weighted (B) image shows the larynx 11.5 years after 
SS-LTR with an anterior and posterior cricoid split (white arrow in B) and a cartilage graft anteriorly. 
The anterior graft shows no resorption and is well depicted (white arrows in A). 
 
Magnetic Resonance Imaging of the laryngotracheal complex. We performed a MRI 
of the laryngotracheal complex, using a MR larynx protocol on a 1.5-T GE 
EchoSpeed scanner (GE Medical Systems, Milwaukee, Wis.). This protocol included 
axial, sagittal and coronal T1-weighted (spin echo, TR/TE 460/ 17 ms) and T2-
weighted sequence (fast spin echo, TR/TE 4460/ 81 ms) with a slice thickness of 4 
mm and 0.4 mm gap in the axial orientation and 3 mm and 0.3 mm gap in the other 
directions. In patient II we used a quadriture coil, normally used for knee imaging. In 
patient I and III, we performed a MRI with the same MR larynx protocol and an 
additional 3D T1 weighted gradient echo sequence with and without fat saturation, 
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using a special surface coil, designed for imaging the carotid arteries. The slice 
thickness was 1.6 mm in axial planned scans and 1 mm in coronal planned scans.  
 
Discussion 
This is the first case study, to visualize cartilage grafts using a MRI in children after 
SS-LTR. In all three patients the grafts were visible with the MRI technique we used. 
No resorption was seen. There was no cartilage-cartilage connection but the cartilage 
grafts were in place and connected to its surrounding with what we believe is fibrous 
tissue. This confirms earlier studies in animals and in humans2,5,6. A possible 
explanation could be that perichondrium prevents infection of the cartilage and 
thereby resorption 2. The survival of cartilage covered with perichondrium is believed 
to be much better because perichondrium prevents infection of the cartilage2. 
Another important factor in graft survival is given by Albert et al. in 19897. They 
describe that cartilage damage during the operation promotes granulation with 
ingrowth of granulation tissue in the cartilage which leads to resorption. 
We have shown that cartilage grafts can be made visible with a special MRI-
technique presented here and we have shown that cartilage grafts with 
perichondrium will not resorp in time. 
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Abstract  
Objective. Surgical manipulation of cartilage tissue is associated with chondrocyte 
death in the wound edges that hinders integration. The objective of this study was to 
evaluate the effect of a short course of treatment of a cartilage graft with a 
combination of hyaluronidase and collagenase on chondrocyte density and 
integrative capacity. 
Methods. Cartilage explants were treated with enzymes for various time periods and 
at various concentrations. A central core was punched out of a larger explant, treated 
with enzymes, re-implanted and placed subcutaneously in athymic mice. The number 
of chondrocytes in wound edges was counted and the integrative capacity of the 
grafts was evaluated histological. 
Results. Treatment with collagenase for 48 hours led to a significant increase in the 
number of vital chondrocytes and restored it to normal after 14 days of culture. 
Treatment with hyaluronidase and collagenase for 48 hours further increased 
chondrocyte densities to supra-normal values. Shortening the treatment to 1 hour 
restored the chondrocyte density to normal after 14 days of culture. In vivo integration 
experiments showed increased chondrocyte densities in treated wound edges and 
extra-cellular matrix fibers crossing over from enzyme-treated parts to untreated 
parts.  
Conclusion. Short-duration treatment of a cartilage graft with a combination of 
hyaluronidase and collagenase increases cell density at wound edges and promotes 
integrative repair.  
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Introduction 
Cartilage surgery constitutes a major part of several surgical disciplines such as 
orthopedics, otorhinolaryngology, and plastic and reconstructive surgery. In the field 
of otorhinolaryngology and head and neck surgery, cartilage is used primarily in 
laryngotracheal reconstructions and operations involving the auricle and the nose. 
The success of the use of cartilage grafts in head and neck surgery depends on the 
quality of integration of the graft with the surrounding cartilage structures1-3. 
Depending on the location in which the graft is used, failure of repair can result in 
severe airway obstruction or gross deformation of the ear or nose. As such, attempts 
should be made to ensure a significant and durable repair. However, cartilage is 
known to possess a poor intrinsic repair capacity. Both in vivo and in vitro studies 
have shown chondrocyte death in cartilage wound edges2-5. This leads to the 
formation of an acellular band leaving avital tissue in the area in which integrative 
cartilage repair is highly required. The cells adjacent to this area would normally 
become increasingly active and undergo proliferation; however, they are not able to 
repair the wound because of the interposition of this acellular tissue and the inability 
of chondrocytes to migrate through the tight extracellular matrix2,3,6. The lack of 
matrix-producing cells in the area in which integration is required may be the limiting 
factor. 
Several enzymatic digestions have been used in an experimental setting in order to 
increase the initial adhesion of cells or cartilage tissue to host cartilage wound 
edges7-9. Previously, we showed that treatment of an explant with collagenase for 48 
hours restored the number of vital chondrocytes in the lesion edges back to normal 
values after 14 days of culture4. These results indicate positive effects of this 
treatment on the process of integrative cartilage repair.  
The purpose of the present study was to shorten the collagenase enzyme treatment 
period, thereby increasing the potential clinical application of the treatment to 
surgery. Shortening the treatment period, however, would eventually require 
potentiating the effect of collagenase with another enzyme. Removal of 
proteoglycans with the enzyme hyaluronidase could facilitate the action of 
collagenase4. We tested the effect of treatment with a combination of hyaluronidase 
and collagenase in various concentrations and for various periods of time (down to 1 
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hour) on the number of viable cells in wound edges during culture follow-up. Finally, 
the effect of enzyme treatment of the graft only on integration with surrounding 
cartilage was evaluated by subcutaneous implantation of constructs in athymic mice. 
 
Methods 
Testing enzyme treatment protocols. Full-thickness articular cartilage samples were 
harvested from the metacarpophalangeal joints of 6 months old calves, within 6 hours 
after slaughter, under sterile conditions with 4 mm dermal biopsy punches (Stiefel, 
imported by Bipharma, Weesp, the Netherlands). Explants were collected in culture 
medium and randomly divided into treatment groups. Before to culture, cartilage was 
either kept at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F12 
(Gibco, Grand Island, New York, USA) supplemented with 2% fetal calf serum (FCS) 
or treated with highly purified collagenase VII (Sigma-Aldrich Chemie BV, 
Zwijndrecht, the Netherlands) and/or hyaluronidase type I-S from bovine testes 
(Sigma-Aldrich Chemie BV, Zwijndrecht, the Netherlands) in DMEM/Ham's F12 
supplemented with 2% FCS. Various enzyme concentrations were used 
(hyaluronidase 0.1% and 3% and collagenase 10 U/mL, 300 U/mL, 600 U/mL) with 
treatment time periods of 48 hours and 1 hour (Figure 4.1). The extracellular matrix of 
cartilage mainly consists of proteoglycans and collagens. Hyaluronidase was used to 
remove proteoglycans and collagenase was used to remove collagens. When 
hyaluronidase is used first, the cartilage becomes more susceptible to collagenase 
treatment. The explants were subsequently washed thoroughly with medium and 
cultured for 14 days at 37º C in a humidified incubator 5% carbondioxide in separate 
wells with DMEM/Ham’s F12 medium supplemented with 10% FCS and 25 µg/mL 
ascorbic acid 2-phosfate (Sigma-Aldrich Chemie BV), 0.5 µg/mL Fungizone, and 50 
µg/mL gentamicin. The medium was changed three times a week. Finally, the 
explants were evaluated histological. 
 
Integration experiment. Full-thickness explants were harvested using 8 mm dermal 
biopsy punches. A central core was punched out using a 3 mm punch to divide the 8 
mm diameter discs into final explant rings (8 mm outer diameter) and explant cores 
(3 mm outer diameter). The inner cores were either treated for 1 hour with a 
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combination of 3% hyaluronidase and 300 U/mL collagenase suspended in medium 
(DMEM/Ham's F12) supplemented with 2% FCS or left in medium with 2% FCS. 
Then the samples were thoroughly washed in culture medium and the 3 mm inner-
cores were re-implanted in their accompanying 8 mm outer ring. These constructs 
were then implanted in separate subcutaneous pockets on the back of athymic mice 
(BALB-C nu/nu; Harlan, Horst, the Netherlands) with approval of the local animal 
ethical committee (Protocol No. 126-01-01). Each mouse carried four constructs: two 
in the back and two in the front (n=12 for the enzyme-treated group and n=6 for the 
control group). After 5 weeks the mice were sacrificed and the constructs were 
harvested (Figure 4.2). 
 
 
Figure 4.1. Schematic overview of the 7 different enzymatic treatment protocols used. Before culture, 
full-thickness articular cartilage explants were kept in culture medium or were treated with highly 
purified collagenase and/or hyaluronidase in medium with 2% fetal calf serum. Various enzyme 
concentrations, marked A-H, were used in treatment time periods of 48 hours and 1 hour. 
 
Histology. To evaluate the effect of enzyme treatment we focused on evaluating the 
number of vital cells in the wound area. Previous studies have indicated that the 
number of vital cells in the wound area is an important prerequisite for integrative 
cartilage repair4,6. Therefore, cartilage discs from all experiments were fixed in 4% 
phosphate-buffered formalin, processed, and embedded in paraffin for histology. By 
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means of a microtome, 6 µm paraffin sections with at least 70 µm interval were cut, 
mounted on slides and stained with heamotoxylin and eosin for evaluation of 
chondrocyte viability and quantification of cell density. Nuclear and cytoplasmatic 
changes as described by Kim and Song in 199910 were used to judge cell viability or 
cell death. Only cells with visible nuclei being evaluated. The wound edge was 
defined as a band of 150 µm from the lesion edges. The central part of the explant, 
one mm distance from the lesion’s edge was defined as unwounded cartilage. Vital 
looking chondrocytes were counted in the superficial zone (100 µm from the surface 
down), the deep zone (150 µm from the base up), and the middle zone (between the 
superficial and deep zones)11. Cell counts were calculated per square millimeter of 
both unwounded and wounded areas at 400 x magnifications with a grid containing 
50 x 50 µm boxes. We used the average of two to four different sections counting the 
chondrocytes in two of each zone. 
 
 
Figure 4.2. Schematic representation of the integration experiment. Full-thickness 8 mm cartilage 
explants were harvested and 3 mm central core was punched out, resulting in outer ring and inner 
core explant. Inner cores were treated with enzymes or kept in control medium. The inner cores were 
subsequently re-implanted into outer rings and implanted in athymic mice for 5 weeks. Histologic 
sections were cut as indicated. Counting of viable cells was done in wounded and unwounded areas, 
in superficial, middle and deep layers. 
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In the integration experiment, viable cell counts of the enzyme-treated area (wound 
edge of the inner core) were compared with the non-enzyme treated area (outer 
wound edge of the outer ring). In addition, the percentage of the inner core interface 
area that was connected to the outer ring was scored in two to four different sections 
and an average was calculated for each construct. The presence of integration of 5% 
or more of the interface area was calculated resulting in an incidence of integration. 
Integration less than 5% was considered as no integration.  
To evaluate the matrix in the integration area, we stained sections with 0.04% 
thionine in 0.01mol/L aqueous sodium acetate or with 0.1% Sirius Red F3BA in a 
saturated picric acid solution. Furthermore, cryosections were stained for procollagen 
type I (M38 1:100; Developmental Studies Hybridoma Bank [DSHB], maintained by 
the Department of Pharmacology and Molecular Sciences, John Hopkins University 
School of Medicine, Baltimore Maryland, and the Department of Biological Sciences, 
University of Iowa, Iowa City, Iowa, under contract N01-HD-6-2915 from the national 
institute of child health and human development) and collagen type II (II-II6B3 1:100, 
DSHB). Pretreatment with 1% hyaluronidase (Sigma-Aldrich Chemie BV) was used 
to unmask the epitopes. All primary antibodies were previously complexed with goat 
Fab-fragment against mouse conjugated with alkaline phosphatase (GAMAP, 1:400, 
Immunotech, Marseilles, France) at 4°C overnight. After coupling 0.1% normal 
mouse serum was added 2 hours before application to the sections to capture the 
unbound GAMAP, after which the antibody solution was used on the slides for 2 
hours at room temperature. The sections were subsequently incubated for 30 
minutes with alkaline phosphatase anti-alkaline phosphatase (APAAP, 1:100, 
Dakopatts, Copenhagen, Denmark). New Fuchsine substrate (Chroma, Kongen, 
Germany) was used for color development. Negative controls were subjected to the 
same protocol with omission of the primary antibody. 
 
Statistical analysis. We finally had seven to 18 samples for each experimental group 
of the in vitro experiment, 12 samples for the enzyme-treated group and six for the 
control group of the in vivo experiment. The results are expressed as mean  SD. 
Differences between enzymatic treatment groups, unwounded areas and control 
groups were calculated with the Kruskall-Wallis test. Differences between individual 
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groups were calculated using the Mann-Whitney U test. For the integration 
experiment, the incidence of integration was calculated using the Fischer’s exact test. 
For all tests, p values of less than or equal to .05 were considered statistically 
significant. 
 
Results 
After harvesting the explants, we observed cell death at the wound edges (Figure 
4.3) of the control explants, leading to a decrease in the number of vital chondrocytes 
as compared to unwounded cartilage after 14 days of culture (Figure 4.4, group A). 
This decrease was significant in superficial and middle zones. Treatment for 48 hours 
with hyaluronidase had no positive effect (Figure 4.4, group B). After treatment for 48 
hours with highly purified collagenase type VII (Figure 4.4, group C), a significant 
increase in the number of vital chondrocytes at the wound edge was seen after 14 
days in culture in comparison to the untreated control group in the wounded part 
(group A). This resulted in an amount of vital chondrocytes similar to that in the 
unwounded cartilage at time point zero. Treatment for 24 hours with 0.1% 
hyaluronidase followed by 24 hours with 10 U/mL collagenase (Figure 4.4, group D) 
led to an even larger increase in vital chondrocytes. After 14 days of culture, the 
number of vital chondrocytes in the treated wound edges was significantly higher 
than in the unwounded cartilage at time point zero. Reducing the treatment time to 1 
hour (Figure 4.4, groups E-H) in combination with higher concentrations of 
hyaluronidase and collagenase also led to a significant increase in vital chondrocytes 
in comparison to untreated wound edges (group A) in all treatment protocols tested, 
particularly in the superficial and middle zones. No significant differences were found 
between treatment with 300 U/mL collagenase (group E) and 600 U/mL collagenase 
(group F). Likewise, no significant differences were found between adding 
hyaluronidase and collagenase subsequently for 30 minutes each (group G) and 
adding them combined for 60 minutes (group H). Furthermore after 14 days of 
culture, the chondrocyte densities in treated wound edges were not significantly 
different from unwounded cartilage at time point zero.  
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 Figure 4.3. Chondrocyte death in the wound edges (H&E, original x100). Fourteen days after 
wounding acellular band is visible at wound edge (circled). Left is the superficial layer and right is deep 
layer (see page 113 for color figure). 
 
In the in vivo integration experiment, the number of vital chondrocytes in the 
wounded enzyme-treated area was higher than in the untreated area (Figure 4.5 and 
4.6). In the treated group, the inner cores were significantly more often integrated 
with the outer rings than the untreated control group (80% versus to 46%). The 
percentage of the interface area that was integrated was 53% ± 19% for the treated 
group and 39% ± 23% for the control group. On histological cross-section of each 
sample, two integration sides appeared. When we split the treated group into a 
‘’better integration side’’ and a ‘’worse integration side,’’ the averages respectively, 
were 75% ± 19% and 26% ± 31%. The matrix in the integration area stained positive 
with Sirius red and moderately positive with thionine. The connection between the 
enzyme-treated inner core and its untreated outer ring is formed by fibers (that stain 
with hematoxilin and eosin, thionine and Sirius red) crossing over from the treated to 
the untreated part (Figure 4.6C). Immunohistochemical staining indicated that cells 
and the tissue at the interface are positive for collagen type II. When the integration is 
either good or totally absent, collagen type I can be found in only a few cells at the 
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interface. However, in a few cases in which a gap occurred that was filled with 
ingrowing tissue from the surroundings, this interface tissue was positive for both 
collagen I and II. 
 
 
 
Figure 4.4. Effect of enzymatic treatment on number of vital chondrocytes in culture. Vital cell counts 
(mean ± SD) in wound edges of explants after 14 days in culture are presented per square millimeter. 
Number of vital chondrocytes in unwounded cartilage at time point zero is indicated by dashed line. 
Asterisk  indicates statistically significant difference from unwounded cartilage at time point zero (p  
0.05). See Figure 4.1 for specification of group A-H. A) Superficial zone. B) Middle zone. C) Deep 
zone. 
 
 
Figure 4.5. Effect of enzymatic treatment on number of vital chondrocytes in integration experiment. 
Number of vital chondrocytes (mean ± SD) in the wound edges of the enzyme-treated inner core 
compared to untreated outer wound edges of outer ring after 5 weeks of subcutaneous implantation in 
athymic mice.  
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Figure 4.6. Zone of the enzyme treated cartilage in integration experiment. A) Chondrocyte density at 
the interface of treated inner core (right) and untreated outer ring (left; H&E, original x100). Integration 
area (arrows) shows almost 100% integration. B, C) Magnification of the integration area (H&E, 
original x400). B) More vital chondrocytes are visible in the enzyme-treated inner core (left) in 
comparison with untreated outer ring of the cartilage (right). C) collagen fibers are crossing over from 
the treated part (bottom) to untreated part (top) (see page 113 for color figures). 
 
Discussion  
Integration of a cartilage graft is probably hindered by a lack of matrix-producing cells 
in the interface region. This lack is mainly caused by chondrocyte death and the 
inability of chondrocytes to migrate through the extracellular matrix toward the lesion 
edges, in which integrative repair capacity is required. In previous studies, we 
demonstrated that treatment of articular explants with highly purified collagenase 
results in a significant increase in the number of vital chondrocytes at the wound 
edges in which initial cell death occurs. This “vitalisation” of wound edges, that 
provides vital matrix-producing cells near the cutting surface, was shown to improve 
integrative cartilage repair4. In this study, we have demonstrated that these effects 
can be achieved by treating for only 1 hour with a combination of highly purified 
collagenase and hyaluronidase. It appeared to be possible to add these two enzymes 
simultaneously, facilitating clinical application. Furthermore, in an in vivo integration 
49 
 
experiment in which only the inner core was enzyme-treated, we showed, aside from 
this increase in vital cell numbers, more frequent integration of the extracellular 
matrix with matrix fibers crossing over from the enzyme-treated part to the untreated 
part.  
Complete repair of cartilage wounds or defects requires integration between 
transplanted cartilage and the surrounding cartilage at the recipient site. The fact that 
repair of cartilage lesions more often requires surgical removal or reshaping of 
cartilage, leading to associated chondrocyte death in the lesion edges would make 
failure of integration an inevitable phenomenon4,6,12-14. We propose that for cartilage 
integration viable chondrocytes are necessary in the wound edges. Other authors 
have described this important role of chondrocytes in cartilage repair. Reindel et al.1 
showed that the repair process that forms tissue at the interface between pairs of 
cartilage explants appeared to depend on viable cells. Peretti et al.15 showed that 
chondrocytes grown on dead cartilage matrix produced new matrix that integrated 
individual cartilage pieces with mechanically functional tissue. In our studies, we have 
found a significant increase in the number of vital chondrocytes in the wound edges 
after enzyme treatment of cartilage in comparison to the control group. 
Some studies have examined the ability of tissue-engineered cartilage to be 
integrated into the surrounding tissue by use of a model similar to the one we have 
used16,17. Tissue-engineered cartilage normally contains a higher chondrocyte 
density than native adult cartilage, and its matrix is not as tight. Obradovic et al.16 
demonstrated that immature constructs, created in 5 days, had poorer intrinsic 
mechanical properties than, but integrated more rapidly than, either more mature 
tissue-engineered constructs or native cartilage explants. Enzyme treatment with 
trypsin of the recipient native cartilage further enhanced the integration of 5-day 
constructs, but had little effect on the integration of 5-week constructs or native 
cartilage. Hunter et al.17 investigated the adhesion of four different engineered 
cartilage constructs in an in vitro defect repair model. They used engineered tissue 
containing chondrocytes as inner cores and full-thickness rings of articular cartilage 
(8-mm diameter) of immature cattle as recipient cartilage. The constructs were 
cultured for 20 or 40 days and were analysed mechanically and biochemically. 
Differences in integration between the different engineered cartilages could not be 
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explained biochemically. Hunter did not look in detail at the integration area itself 
though. We previously demonstrated that in constructs of calf cartilage in which both 
the inner core and the outer ring were treated with collagenase and hyaluronidase for 
a total of 48 hours, cell density in the wound edges was increased and interface 
strength was improved18. This finding indicates a relation between cell density in the 
interface edges and the strength of bonding. 
The exact mechanism by which the enzymatic treatment exerts its effects is still 
unclear. Application of enzymes may remove the acellular layer, uncovering an 
activated area of chondrocytes capable of integration. Another possible working 
mechanism of this enzymatic treatment may be the partial degradation of 
extracellular matrix surrounding the wound edge chondrocytes, stimulating 
chondrocyte proliferation and enabling cell migration. In our experiments we saw 
some chondrocyte clusters, indicating cell proliferation. In the integration experiments 
at the time of implantation of the inner core in the outer ring after brief enzyme 
treatment, we noticed a small gap between inner core and outer ring, indicating 
removal of the matrix at the wound edges. So, the effect of enzymatic treatment may 
be caused by a combination of removal of acellular matrix and stimulation of cell 
proliferation and migration.  
The increase in amount of cells is accompanied by an increase in integration. In our 
in vivo integration experiment we saw that 80% of the constructs were integrated 
(defined by a connection between the inner core and outer ring over more than 5% of 
the interface area), whereas in the control group 46% of the constructs showed 
integration. In most cases, sections show integration on one side of the disc but not 
at the opposite interface area. This finding may very well be explained by the size 
reduction of the treated inner core. The side where the inner core made contact with 
the outer ring was integrated, whereas the other side was less integrated because of 
a small gap. This idea is supported by the percentage of the interface that was 
integrated. In total we found an average of 53% of the interface length to be 
integrated; the average for the “better integration sides” was 75%, and for the 
opposite “worse sides,” 26%. Because we have never noticed such a gap with 
previous enzyme treatments (48 hours with lower concentrations of enzymes), further 
optimization of enzyme conditions might be necessary for clinical application. This 
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study however, shows that short enzyme treatment of the graft only has the potential 
to improve cartilage integration.  
 
Conclusion 
We have demonstrated that brief enzymatic treatment with a combination of 
hyaluronidase and collagenase increases the number of vital chondrocytes in wound 
edges and has a positive effect on integrative cartilage repair. The integration 
experiment showed (new) fibers crossing over from enzyme-treated cartilage to the 
untreated part. This finding suggests that enzyme treatment will be favourable for 
integrative cartilage repair. By reducing the treatment time from 48 hours to 1 hour 
and treating the graft only, we are a step closer to the possible clinical application of 
this procedure. More studies need to be undertaken to thoroughly test the safety of 
enzyme treatment in order to prevent harmful effect on adjacent chondrocytes and 
cartilage and to further optimize its efficacy on cartilage integration in vivo. 
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Abstract 
Objective. To investigate whether porous titanium can provide a better support for 
revascularisation of a mucosal graft ideal for tracheal reconstruction. In patients with 
laryngotracheal stenosis or tumor, the mucosa with supporting structures can be 
damaged, resulting in a defect that has to be reconstructed. Autologous tissues like 
cartilage and mucosa have been used for reconstruction. The main problem has 
been incomplete mucosal re-epithelialization. 
Methods. In the first experiment, porous titanium or ear cartilage was combined with 
mucosa and implanted subcutaneously in athymic mice for different periods of time. 
In the second experiment, using rabbits, surgically created defects were 
reconstructed with porous titanium and mucosa on a pedicled fascia flap using a two-
stage procedure. The implants were analyzed with emphasis on angiogenesis and 
mucosal survival. 
Results. Normal mucosa having a submucosal layer with vital cells was noted on top 
of the titanium. Multiple blood vessels were observed extending from the muscle 
layer through the titanium. Cytokeratin expression was detected in the suprabasal 
and basal layers of the mucosal epithelium. In contrast, the mucosa on cartilage 
showed no vital cells and no cytokeratin expression. In the rabbit experiment, all 
animals survived the reconstruction. The titanium was well integrated to the adjacent 
tracheal cartilage and surrounding tissues, supporting a fully vital mucosa. 
Conclusions. Porous titanium is an inert biomaterial that provides support and allows 
easy revascularisation of a mucosal graft. Titanium, in combination with viable 
autologous tissues, is a good alternative for tracheal reconstruction. 
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Introduction 
The surgical repair of laryngotracheal stenosis (LTS), whether it is congenital or 
acquired, remains one of the most challenging aspects of airway management. For 
subglottic and short segment stenosis, repair can be achieved with good results 
using cartilage interposition grafts in cricotracheal split procedures and with 
cricotracheal resection (CTR) followed by end-to-end anastomosis1,2. Resection of 
the trachea theoretically can be performed safely after resection of up to one-half of 
the trachea in adults and one-third in infants and small children. However, long 
segment stenosis involving more than half of the entire tracheal length and re-
stenosis after an initial resection and end-to-end anastomosis, pose a therapeutic 
problem since further resection is usually not possible. For such cases, augmentation 
of the stenotic segment using repair tissues can be a valuable option. 
 
Figure 5.1. A) Titanium plate of 10 X 10 X 2 mm. with pores ranging from 400 to 700 ųm and a 
porosity of 90%. B) Magnification of Figure A (original x10) (see page 115 for color figures). 
 
Ideally, a tissue for laryngotracheal reconstruction would consist of a viable cartilage 
and respiratory mucosal lining similar to that of the native trachea. Unfortunately, 
there is no such composite tissue elsewhere in the body that can meet all these 
requirements. Most of the reconstructive tissues applied clinically lack one or both 
components, leading to the large variation in results. Using tissue-engineering 
techniques, Delaere et al.3 created a prefabricated and prelaminated repair tissue 
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composed of revascularized elastic ear cartilage with buccal mucosal lining and 
applied it clinically with satisfactory results. A major drawback of this technique is the 
long waiting period that is necessary to allow revascularisation of the mucosa and 
remucosalization of the cartilage graft before the whole regenerated tissue can be 
finally transferred to the neck area. Cartilage, by nature, is avascular and possesses 
antiangiogenic properties, making it a less suitable support tissue for mucosal grafts. 
This was clearly shown by Delaere and Hardillo4, when they reconstructed 
circumferential tracheal defects in rabbis with tubed auricular cartilage pre-wrapped 
in vascularized fascia. Despite the improvement of vascularisation around the tube, 
healing through remucosalization only occurred around the anastomotic regions 
leaving the central portions of the grafts bare and partially necrotic. 
 
 
Figure 5.2. The back of an athymic mouse with on the left a cartilage piece with rabbit’s buccal 
mucosa. On the right, a titanium plate with rabbit’s buccal mucosa. This is post termination after 2 
weeks of implantation (see page 117 for color figure). 
 
Because of the limitations of prefabrication using autologous tissues such as the 
combination of cartilage and mucosa, the use of various biomaterials has been 
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attempted. Solid titanium, Medpor, hydroxyapatite5-7 or tissue-engineered cartilage 
with chondrocytes seeded in polypropylene or polyglycolic acid with or without 
mucosal lining 8-10 have been used in experimental settings. The main problem in all 
of these studies is the regeneration of the mucosal lining, as mentioned in a review 
by Tan et al.11. In cases of minor defects, re-epithelialization from the wound edges 
occurred, but for larger defects this process of re-epithelialization proved to be 
insufficient. Previous attempts to improve revascularisation of mucosal grafts using 
perforated cartilage proved to be futile because perforated cartilage lacked the 
necessary support to keep the tracheal lumen open. A possible solution to this 
problem is the use of stable porous biomaterials, which can allow new vessels to 
grow through the pores to revascularize an implanted mucosal component and 
thereby ensure its survival. In addition, the biomaterial of choice should be strong 
enough to keep the airway lumen open, and most important, the material should not 
evoke a foreign body reaction or inflammation. 
 
A B
Figure 5.3. Histological section of human buccal mucosa on top of titanium after 2 weeks of 
implantation. A) Human buccal mucosa (H&E original x2.5). The black material is titanium. The 
mucosa is attached to the titanium. The pores of the titanium are filled with fibrous tissue and blood 
vessels. The white arrows point to the basal layer of the mucosa. B) Magnification (H&E original x10) 
showing the titanium filled with fibrous tissue and blood vessels (white arrows) (see page 115 for color 
figures). 
 
These requirements are met by titanium, a material that has been used for years as 
an implantation material in both orthopaedics and maxillofacial reconstructive 
surgery. Titanium is chemically resistant to the corrosive and oxidative activities of 
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various agents12. It has also been shown to be very well tolerated by animal and 
human tissues, making it a suitable material for tracheal reconstruction. 
We investigated whether human and rabbit buccal mucosa will survive on porous 
titanium in an athymic mice model and in a rabbit tracheal reconstruction model. In 
the athymic mouse model experiment we determined whether angiogenesis will 
occur through the porous titanium, allowing graft survival in comparison with cartilage 
grafts. In the rabbit tracheal reconstruction model experiment, we studied whether a 
construct of porous titanium and mucosa would be tolerated inside the trachea. 
 
Methods 
Porous titanium plates. Porous titanium implants were produced by the polymeric 
sponge replication method. Titanium powders (75% by weight) with a spherical shape 
and mean diameter of 45 μm (Bongen Titanium, Co Ltd, Xián, China) were mixed 
with water (18.5% by weight) to make a titanium slurry. Polyethylene glycol 4000 
(Fluka Chemie GmbH, Delsendorf, Germany) and methylcellulose (MC, Fisher 
Scientific B.V., Landsmeer, the Netherlands) were used as binders (3.5 % by weight). 
One percent by weight of an alkali-free carbonic acid-based polyelectrolyte, Dolapix 
(Aschimmer & Schwarz GmbH, Rhein, Germany), as dispersant 1% by weight of 
ammonia solution (25% by weight, Merck, Darmstadt, Germany), and 1% by weight 
of 1-octanol (Acros Organics, Pittsburgh, Pennsylvania) were mixed in to improve the 
rheological property of the slurry. Porous titanium green bodies were made by 
impregnation of polymeric sponges (Coligen Europe B.V., Breda, the Netherlands). 
The polymeric sponges were thoroughly dipped into the titanium slurry. This dipping 
process was repeated until all the struts of the polymeric sponge were covered with 
slurry. Excess slurry was removed by using a roller-pressing device. After drying, the 
samples were heated to 500ºC in argon to burn out the foam. Finally, the porous 
bodies with pores ranging from 400 to 700 ųm were sintered in a vacuum furnace 
(10-5 mbar) at 1250ºC for 2 hours. Porous tracheal implants with a porosity of 90% 
were sliced using a wire electric discharge machine13 (Figure 5.1). 
 
Human mucosa experiment in athymic mice. Human buccal mucosa (10 X 5 mm) of 
two patients undergoing an intraoral surgical procedure was harvested and used 
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within 1 hour with approval of the local Medical Ethics Committee (protocol No. 
232.997/2003/196). The mucosa was split into two pieces of 5 X 5 mm in size, and 
each piece was placed on the center of a 10 X 10 X 2 mm porous titanium plate and 
fixed with fibrin glue (Tissucol; Baxter, Utrecht, the Netherlands). To avoid any host-
graft rejection, the titanium was sutured on the back muscle of athymic mice (BALB-c 
nu/nu; Harlan, Horst, the Netherlands) with approval of the local animal ethical 
committee (Protocol No. 126-03-01). The mucosa was covered with Neuro-Patch 
(Braun Aesculap AG & CO KG, Tuttlingen, Germany) to prevent adhesion of the 
mucosa to the inner side of the skin and to limit revascularisation of the mucosa from 
the surrounding tissues aside from the back muscle. The mucosa from one patient 
was implanted for 1 week; the mucosa from the other patient was implanted for 2 
weeks. Two mice were used; each animal carrying two pieces of titanium. The mice 
were killed respectively after 1 and 2 weeks and the titanium plates were removed 
including a piece of back muscle. These were embedded in plastic for histological 
analysis. 
 
Rabbit mucosa experiment in athymic mice. Rabbit buccal mucosa (20 X 10 mm) 
was harvested from dead rabbits (acquired from another experiment) within 1 hour 
after euthanasia. The mucosa was split into two pieces of 10 X 10 mm and then 
sutured with Ethilon 6-0 on porous titanium plates or rabbit ear cartilage (from the 
same dead rabbits) of 10x10 mm (Figure 5.1). Both constructs were sutured 
subcutaneously on the back of athymic mice with approval of the local animal ethical 
committee (Protocol No. 126-03-01). The mucosa was covered with Neuro-Patch to 
prevent adhesion of the mucosa to the inner side of the skin and to limit 
revascularisation from the surrounding tissues aside from the back muscle. Each 
mouse carried a titanium construct and a cartilage construct on the back (Figure 5.2). 
Both constructs were covered with mucosa from the same rabbit. A total of three 
mice were used. The mice were killed after 1, 2, and 4 weeks respectively. Half of the 
mucosa was dissected carefully from the titanium or the cartilage for cytokeratin (CK) 
staining to evaluate the basal layer and vital keratinocytes of the epithelium. The rest 
of the mucosa still attached to the graft was embedded either in plastic for the 
titanium constructs or in paraffin for the cartilage grafts for histological analysis with 
emphasis on angiogenesis and mucosal survival. 
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Tracheal reconstruction experiment in rabbits. Three male New Zealand white rabbits 
(each weighing 3 kg) were used in a two-stage procedure with approval of the local 
animal ethical committee (Protocol No. 126-03-01). In the first stage, the rabbits were 
anesthetized intramuscularly with 4cm3 of xylazine-hydrochloride, 2% (Rompun; 
Brussels, Belgium) and ketamine hydrochloride 10% (Ketalin; Apharmo, Duiven, the 
Netherlands). The left thoracic skin was incised, and a concave-shaped titanium plate 
of 20 X 5 mm in size together with a section of harvested full-thickness buccal 
mucosa of 20 X 5 mm in size was sutured with Ethilon 6-0 on the left lateral thoracic 
fascia flap. The titanium was covered with Neuro-Patch to prevent adhesion of the 
mucosa to the skin. The skin was closed in one layer using Vicryl 2-0.  
 
Figure 5.4. Rabbit buccal mucosa. A) Rabbit buccal mucosa on top of titanium (H&E magnification 
original x25). Note the intact basal layer as indicated by the black arrows. B) Rabbit buccal mucosa on 
top of ear cartilage (H&E magnification original x25). In the middle of the picture the cartilage is visible 
with its chondrocytes (black arrows). There is no connection between the mucosa and the cartilage. 
The basal layer of the mucosa is not visible (white arrows) (see page 117 for color figures). 
 
In the second stage, 2 weeks after implantation, the skin was incised, and the left 
thoracic fascia flap was isolated on the lateral thoracic vessels and rotated under the 
skin into the neck region of the rabbit. Using a midline incision, the anterior cervical 
trachea was dissected and a defect of 20 X 5 mm was created in the anterior cricoid 
and the first three tracheal rings. The defect was one-third of the total diameter. The 
mucosa/titanium attached to the fascia flap was then sutured with Ethilon 6-0 into the 
defect with the buccal mucosa facing the tracheal lumen. The skin was closed in 
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three layers. After 6 weeks, the rabbits were killed with an overdose of pentobarbital, 
and the cricotracheal complex was dissected out. The trachea was opened 
posteriorly in a vertical line and photographed. The trachea was then embedded in 
plastic for histological analysis. 
Histological analyses. In the human mucosa-athymic mice experiment, all pieces 
were embedded in plastic and sections of 50 µm in thickness were made using a 
diamond saw (Leica SP1600; Leica AG, Glattbrugg, Switzerland) and stained with 
hematoxilin and eosin. 
 
Figure 5.5. Cytokeratin staining (CK13) on rabbits buccal mucosa after 2 weeks of implantation with a 
clear basal membrane (black arrows) and suprabasal keratinocytes of vital mucosa (original 
magnification x100, visualization with New Fuchsin, counterstain with Gill’s haematoxylin) (see page 
117 for color figure). 
 
In the rabbit mucosa-athymic mice experiment, half of the mucosa was dissected 
carefully from the titanium or the cartilage and was snap frozen in liquid nitrogen. Six 
micron sections were cut for CK staining (see next subsection) to evaluate the basal 
layer and vital keratinocytes of the epithelium. The rest of the mucosa still attached to 
the graft was embedded in either plastic for the titanium constructs or in paraffin for 
the cartilage grafts. For the titanium, 50 µm sections were made using a diamond 
saw (Leica SP1600). For the cartilage, 6 µm sections were made using a microtome 
(Leica RM 2135). Both the plastic and the paraffin sections were stained with 
hematoxilin and eosin. In the tracheal reconstruction experiment, 50 µm sections 
were made using a diamond saw (Leica SP1600) and stained with hematoxilin and 
eosin. 
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Immunohistochemical analyses in the athymic mice. Cytokeratin expression of the 
mucosa was evaluated using antibodies against CK10 (Euro-diagnostica, Arnhem, 
the Netherlands), CK13 (Euro-diagnostica), CK14 (Immunotech, Marseille, France) 
and CK16 (Nove Castra, Newcastle, England). CK10 and CK13 are markers for the 
suprabasal layers of stratified mucosa, CK14 is a marker for the basal layers of 
stratified epithelia, and CK16 is a marker for suprabasal cells of hyperproliferative 
squamous epithelia. Positive controls of these CK’s were performed on a piece of 
rabbit buccal mucosa. 
All samples were fixed in formalin, processed in paraffin wax, and sectioned at a 
thickness of 6 µm. To stain mouse sections with a mouse antibody, the primary and 
secondary antibody (alkaline phosphatase conjugated goat anti-mouse IgG, 
Immunotech) had to be prelinked overnight14. For CK10, CK14 and CK16 sections 
were postfixed in formaldehyde, 4% for 10 minutes after deparaffinization and 
antigen retrieval was performed out by immersing sections in sodium citrate buffer, 
0.01 M (pH 6.0) and keeping them at boiling temperature for 10 minutes using a 
microwave oven. Cytokeratine 10 staining required antigen retrieval with trypsin, 
0.075%, in phosphate-buffererd saline for 30 minutes at 37°C. After retrieval, 
nonspecific reactions were blocked using 10% normal goat serum (Sigma-Aldrich, St 
Louis, Missouri) for 30 minutes followed by incubation with the pre-linked antibodies 
for 1 hour and alkaline phosphatase (alkaline phosphatase anti-alkaline phosphatase 
[ASPAAP], DakoCytomation, Glostrup, Denmark) for 30 minutes. Visualisation was 
performed with an alkaline phosphatase substrate New Fuchsin (Chroma, Köngen, 
Germany). Sections were counterstained with Gill haematoxylin (Sigma-Aldrich) for 1 
minute. The negative control was performed using a nonspecific mouse IgG1 
(DakoCytomation, X0931) also prelinked with the alkaline phosphatase conjugated 
goat antimouse IgG15. 
 
Results 
Viability of human mucosal grafts on titanium. Vital mucosa was seen attached to the 
titanium (Figure 5.3A). On histological evaluation, normal mucosa with a submucosal 
layer was visible with vital cells. Multiple blood vessels were observed growing from 
the muscle layer into the titanium in the direction of the mucosa (Figure 5.3B). This 
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process was seen as early as 1 week with more pronounced vessel formation after 2 
weeks.  
Viability and morphology of rabbit mucosal grafts on titanium versus cartilage. Vital 
buccal mucosa, adherent on the titanium was observed in all sections (Figure 5.4A). 
The mucosa had a normal structure consisting of epithelial cells and a submucosal 
layer. As early as 1 week post implantation, new blood vessels were already visible, 
originating from the back muscle of the mouse and growing into the titanium up to the 
submucosal layer.  
A normal basal layer was present in all three mice (1, 2 and 4 weeks after 
implantation) as shown in Figure 5.5. The suprabasal layers were more pronounced 
after 1 and 2 weeks. Cytokeratin expression was detected in the suprabasal (CK10 
and CK13) and basal (CK14) layers of the mucosa on the titanium. No expression of 
CK16 was seen. 
The mucosa on the cartilage showed varying degrees of necrosis and no 
revascularisation. The mucosal layer was not integrated with the ear cartilage (Figure 
5.4B). No CK expression was detected in this material. 
Performance of titanium-mucosal graft construct in tracheal reconstruction. All three 
rabbits survived the two operations until the end of the experiment, 6 weeks after 
tracheal reconstruction. In two rabbits the titanium was covered with mucosa and the 
airway lumen was open (Figure 5.6A and B). Granulation tissue was seen in only one 
of the suture points in one rabbit. The third rabbit became dyspnoeic at the end of the 
experiment. On dissection of the cricotracheal complex, a segment of the titanium 
was noted to have shifted inside the trachea.  
Histological evaluation of the mucosa and the titanium showed revascularisation of 
the mucosa through the titanium and a vital mucosa (Figure 5.6C). In one rabbit 
some granulation tissue was found around a suture, as noted on macroscopic 
inspection. Otherwise, no signs of inflammation or foreign body reaction were visible. 
The constructs were well integrated with the adjacent cartilage and soft tissues 
(Figure 5.6D). 
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Figure 5.6. Cricotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. A) The 
titanium is visible under the mucosa with stitches (black arrows). The titanium is covered with a thin 
layer of mucosa. B) Histological cross-section through the trachea (H&E). The short black arrow 
indicates the opening in the posterior plane. The white arrow indicates the pedicled fascia. Note the 
integration of the titanium, which provides a concave tracheal lumen. A thin layer of mucosa is 
covering the titanium. Some granulation tissue is present on the left side of the titanium just inside the 
tracheal lumen (long black arrow). C) The pores in the titanium (H&E, original magnification x200). 
Notice the presence of fibrous tissue filling the pores of the titanium. The black arrow is pointing at a 
bloodvessel. D) The integration area between the cartilage and titanium (H&E original magnification 
(x100). Notice a tight connection is present between the titanium and the cartilage (black arrow) (see 
page 119 for color figures). 
 
Discussion 
Surgical repair of the trachea remains a therapeutic challenge. Although long-
segment stenosis is a rare entity, acquired stenosis is a growing problem owing to 
advances in medical care that have result in increased numbers of critically ill 
patients requiring chronic mechanical ventilation16.  
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At present, subglottic and short segment stenosis at present are mainly repaired by 
cartilage interposition grafts in cricotracheal split procedures and with CTR followed 
by end-to-end anastomosis17. Long-segment stenosis involving more than half of the 
entire tracheal length and re-stenosis after an initial resection and end-to-end 
anastomosis, continues to be a therapeutic problem because further resection is 
usually not possible. 
There are a couple of clinical case reports in which a neo-trachea was formed using 
autologous costal cartilage or seeded chondrocytes in a marlex mesh tube with 
palatal mucosal graft18,19. All patients survived the procedures, but the disadvantage 
was the need for two or three steps, which were necessary to create the neo-trachea. 
Another study described a series of 112 patients in which preserved allografts from 
dead people were used for tracheal reconstruction in long segment stenosis20. 
However, they reconstructed only a part of the trachea, and, more over, the use of 
homografts in this time of Creutzfeld Jacob and other possible diseases would not be 
the first choice of therapy. 
To improve reconstruction of the trachea, several experimental approaches have 
been followed in animal models. As mentioned in our introduction, autologous 
cartilage with laryngotracheal frameworks from solid titanium, Medpor or 
hydroxyapatite5,7, tissue-engineered cartilage with chondrocytes seeded in 
polypropylene or polyglycolic acid with or without mucosal lining8-10 and prefabricated 
tubes with cartilage strips and a vascularized muscle or fascia21 have all been used. 
They all had the same problem, that is, the restoration of the mucosal lining through 
re-epithelialization. This occurred from the wound edges in small defects, but for 
larger defects this process of re-epithelialization was not sufficient. The key to the 
problem is speeding up the process of revascularisation. This can be achieved with 
the use of porous materials, in which new vessels can grow through the pores to 
reach the epithelializing surface. Porous hydroxyapatite was used in rabbits by Triglia 
et al.22. Their main problem was the fixation of the hydroxyapatite to the surrounding 
tissue. Schultz et al.23 implanted porous titanium tracheal prostheses into 17 rats. Six 
rats died, five of them because of displacement of the titanium or sealing of the 
prosthesis from overgrowth of granulation tissue. The titanium, however, was well-
tolerated by the surrounding tissue as seen on histological analysis. 
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An optimal tissue for tracheal reconstruction should have three different components: 
a support tissue to keep the lumen open, a good epithelial lining, preferably 
consisting of mucosa, and a vascular supply3. The results of our study showed that 
these criteria can be met by using porous titanium in combination with autologous 
tissues. Titanium is sturdy enough to keep the lumen open, and the porous matrix 
offers the opportunity for blood vessels to grow into the scaffold. This allows re-
epithelialization and survival of a mucosal graft. An angiogenic effect of titanium clips 
in rats has been described by Foschi et al.24. They observed new blood vessels in 
the mesentery of rats after creating a wound which was closed with titanium clips. 
Titanium has also been described to be an ideal biomaterial in a septic environment 
like the trachea, and our rabbit study confirmed this. No inflammatory response or 
foreign body reactions were observed after 6 weeks. 
To our knowledge, this is the first study that used porous titanium in combination with 
mucosal grafts, and it clearly showed histological evidence of revascularisation of the 
mucosal graft. After 1 week, new blood vessels were observed growing from the 
underlying tissue through the titanium scaffold. The presence of the Neuro-patch 
eliminated possible revascularisation of the mucosa coming from the surrounding 
tissues other than the back muscle. The importance of this revascularisation was also 
highlighted by the observation that the mucosal grafts in combination with cartilage 
grafts appeared non-vital. 
Mucosal grafts can be fixed on the scaffold using stitches or glue. In our first study 
using human mucosa, human fibrin glue (Tissuecol) was used. Glue is easy to apply, 
and the mucosa remained well fixed on the titanium, even 4 weeks after implantation. 
Stitching the mucosa might last longer, but some factors have to be taken into 
consideration, namely, that the tissue might be harmed by the stitches, it might partly 
detach and, depending on the material used, granulation tissue may form around the 
stitches. For the rabbit experiments, we did choose to use stitches to avoid possible 
reactions against the human fibrin glue. In theory, however, fibrin glue can offer an 
advantage by stimulating angiogenesis25. 
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Conclusion:  
Our experiments showed that reconstruction of a rabbit laryngeal defect using 
composites of porous titanium and mucosal grafts is a promising technique. Porous 
titanium is an inert biomaterial that allows easy penetration of blood vessels and 
survival of the mucosa. The morphologic characteristics of the mucosa were 
preserved, indicating a functional tissue. Future experiments have to fine-tune the 
use of such composite grafts for clinical use, especially when larger and circular 
defects have to be reconstructed. 
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Abstract 
Objective. Laryngotracheal reconstruction requires a supportive structure with a 
mucosal lining which needs a vascular supply in order to regenerate properly. We 
investigated the necessity of a vascular carrier and mucosal graft when using porous 
titanium for laryngotracheal reconstruction. 
Methods. Surgical defects of the laryngotracheal complex in 22 rabbits were 
reconstructed with (I) porous titanium implanted on a vascularized fascia combined 
with a buccal mucosal graft (first stage) before transposing to the neck area (second 
stage); (II) porous titanium implanted on a vascularized fascia (first stage) combined 
with a mucosal graft (second stage); (III) porous titanium on a pedicled fascia flap; 
and (IV) porous titanium alone.  
Results. The grafts were tolerated well. Re-epithelialization occurred in all groups. 
Normal mucosa with a submucosal layer containing vital cells was noted on the 
titanium. Blood vessels were grown in the pores of the titanium scaffold to supply the 
overlying mucosa. The scaffold was well integrated in the adjacent tracheal cartilage 
and surrounding tissues, except in the two cases that showed titanium displacement. 
Inflammation and granulation formation were seen in most rabbits in groups I and II, 
initiated probably by the use of buccal mucosal grafts. 
Conclusion. Reconstruction of a rabbit’s trachea using composites of porous titanium, 
mucosal grafts and a fascia flap is feasible. Titanium seems to meet the requirements 
needed for closing a small defect of the tracheal wall and allows for re-
epithelialization. For larger defects a vascular carrier with a mucosal graft is probably 
indispensable to ensure the process of re-epithelialization.  
 
 
 
 
74 
 
Introduction 
Creating a new functional laryngotracheal tissue is the ultimate goal for patients with 
laryngotracheal stenosis (LTS) and with re-stenosis after failed resections and 
anastomoses, and after tracheal resection for tumours of the laryngotracheal 
complex and the surrounding tissues. 
The limitations of composite autologous tissues, such as cartilage and mucosa, 
stimulated the introduction of various biomaterials. Solid titanium, Medpor, 
hydroxyapatite1-3 or tissue-engineered cartilage with chondrocytes seeded in 
polypropylene or polyglycolic acid matrices have been used in experimental settings4-
6. The main problem in all these studies is the regeneration of the mucosal lining, as 
mentioned in a review by Tan et al.7. In cases of minor defects, re-epithelialization 
from the wound edges occurred successfully, but for larger defects this process of re-
epithelialization proved to be insufficient, such that mucosal grafts need to be added 
to the constructs. These mucosal grafts, on the other hand require a good vascular 
bed or matrix in order to ensure its survival.  
In humans, a neo-trachea was formed using autologous costal cartilage or seeded 
chondrocytes in a marlex mesh tube with palatal mucosal graft8,9. All patients 
survived these procedures, but the disadvantage was the need for staged surgery, 
which is necessary to create the neo-trachea. Recently, Machhianrini et al.10 
described a clinical case where they used a homograft trachea bioengineered with 
autologous stem cells with success. This procedure is technically challenging and not 
suitable for large-scale application. 
In the experimental setting in rabbits, a neo-trachea was created from a cartilage 
tube wrapped with a fascia flap to improve vascularisation around the tube. Healing 
through remucosalization only occurred around the anastomotic regions, leaving the 
central portions of the grafts bare and partially necrotic11. Although the use of a 
cartilage graft to support the structure would make sense, cartilage does not support 
vessel ingrowth well and therefore is not a suitable material for mucosa regeneration. 
The process of re-epithelialization from the wound edges and revascularisation of 
mucosal grafts can be improved by the use of a stable porous biomaterial. This 
biomaterial should allow new vessels to grow through the pores, thereby creating a 
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vascular bed to support re-epithelialization and survival of the implanted mucosal 
component. The material should not evoke inflammation or a foreign body reaction.  
Titanium is a material that has been used for years as implantation material in a 
variety of anatomical sites. Porous titanium is a relatively new product that allows 
blood vessels to grow through its pores12. Previously, we demonstrated that mucosal 
grafts can survive on porous titanium plates implanted on the back of athymic 
mouse13. Multiple blood vessels extending from the muscle layer through the porous 
titanium were observed as early as 1 week after implantation. Using these combined 
constructs of a porous titanium plate with a mucosal graft attached to a vascularized 
fascia, we successfully reconstructed surgically-created laryngotracheal defects in 
rabbits 13. 
The aim of this study is to investigate the necessity of a vascular carrier when using a 
porous titanium implant with or without a mucosal graft component in the 
reconstruction of full-thickness (cartilage and mucosa) laryngotracheal defects in 
rabbits. The general question is whether the rabbits can survive such reconstructions 
for a specific period of time and more specific questions are: a) does a fascia flap in 
combination with a mucosal graft and titanium lead to better results, b) is it necessary 
to implant the mucosal graft on the titanium in a first stage to allow vascularisation, or 
can we use the mucosal graft directly after harvesting; and c) is it necessary to use a 
fascia flap as a vascular supply?  
 
Figure 6.1. Curved titanium plate of 20 X 5 mm and a thickness of 2 mm, with pores in the range 400-
700 ųm and a porosity of 90% (see page 121 for color figure). 
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Methods 
Porous titanium plates. Porous titanium plates with a porosity of 90% were sliced 
using a wire electric discharge machine in curved plates of 20 X 5 mm (Figure 6.1). 
Porous titanium implants were produced by the polymeric sponge replication method 
as described in our previous article13.  
 
 
Figure 6.2. Cervical area of the rabbit exposed (A) before and (B) after creation of the full-thickness 
defect (through cartilage and mucosa) measuring 20 X 5 mm in the anterior cricoid and the first three 
tracheal rings. The defect is one-third of the total circumference. The head is downwards in this image 
(see page127 for color figures). 
  
Figure 6.3. Schematic drawing of a rabbit with the titanium plate placed on the left lateral thoracic 
fascia flap (see page 119 for color figure).  
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Surgical procedures. Male New Zealand white rabbits (each weighing 3 kg) were 
used with approval of the local animal ethical committee (Protocol No. 126-03-01). 
For each of the four groups six rabbits were planned. Initially, three rabbits were 
operated on in each group. When there were no signs of dyspnea or stridor, the 
remaining three rabbits in each group were operated.  
The rabbits were anesthetized intramuscularly with 4cc of xylazine-hydrochloride, 2% 
(Rompun; Brussels, Belgium) and ketamine hydrochloride, 10% (Ketalin; Apharmo, 
Duiven, the Netherlands). The anterior cervical trachea was dissected using a midline 
vertical neck incision. (Figure 6.2A) 
 
 
Figure 6.4. Schematic drawing of the four different groups. Groups I and II are operated on using a 
two-stage procedure; groups III and IV are operated on using a one-stage procedure (see page 123 
for color figure). 
 
Group I: porous titanium initially implanted on a vascularized fascia and 
combined with buccal mucosal graft (first stage) before transposing to the 
neck area (second stage) 
In the first stage, the left thoracic skin was incised and a concave shaped titanium 
plate of 20 X 5 mm, together with harvested full-thickness buccal mucosa of 20 X 5 
mm was sutured with Ethilon 6-0 on the left lateral thoracic fascia. The titanium was 
covered with Neuro-Patch (Medcompare, USA) to prevent adhesion of the mucosa to 
the skin. The skin was closed in one layer using Vicryl 2-0.  
In the second stage, 2 weeks later, the skin was incised and the left thoracic fascia 
flap was isolated on the lateral thoracic vessels and rotated under the skin into the 
neck region of the rabbit. Using a midline incision, the anterior cervical trachea was 
dissected and a defect of 20 X 5 mm was created in the anterior cricoid and the first 
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three tracheal rings. The defect was one-third of the total circumference (Figure 
6.2B). The mucosa-titanium construct attached to the fascia flap was sutured with 
Ethilon 6-0 into the defect, with the buccal mucosa facing the tracheal lumen. The 
skin was closed in three layers.  
In this group only three of the six rabbits were operated because one of the rabbits 
became dyspnoeic at the end of the experiment. Upon dissection of the cricotracheal 
complex, a segment of the titanium was noted to have shifted inside the trachea.  
 
Group II: porous titanium implanted on a vascularized fascia (first stage) and 
combined with a buccal mucosal graft (second stage). 
In the first stage, the left thoracic skin was incised and a concave shaped titanium 
plate of 20 X 5 mm was sutured with Ethilon 6-0 on the left lateral thoracic fascia. The 
titanium was covered with Neuro-Patch to prevent adhesion of the titanium to the 
skin. The skin was closed in one layer using Vicryl 2-0. 
In the second stage, 2 weeks later, the skin was incised and the left thoracic fascia 
flap was isolated on the lateral thoracic vessels and rotated under the skin into the 
neck region of the rabbit. Harvested full-thickness buccal mucosa of 20 X 5 mm was 
sutured on the titanium. Using a midline incision, the anterior cervical trachea was 
dissected and a full-thickness defect of 20 X 5 mm was created in the anterior cricoid 
and the first three tracheal rings. The defect was one-third of the total circumference. 
The mucosa-titanium construct attached to the fascia flap was sutured with Ethilon 6-
0 into the defect with the buccal mucosa facing the tracheal lumen. The skin was 
closed in three layers.  
 
Group III: porous titanium with vascularized fascia (single stage procedure). 
The left thoracic skin was incised and a concave shaped titanium plate measuring 20 
X 5 mm was sutured with Ethilon 6-0 on the left lateral thoracic fascia (Figure 6.3). A 
flap was then isolated on the lateral thoracic vessels and rotated under the skin to the 
neck region. Using a midline incision, the anterior cervical trachea was dissected and 
a full-thickness defect (cartilage and mucosa) of 20 X 5 mm was created in the 
anterior cricoid and the first three tracheal rings. The defect was one-third of the total 
circumference. The titanium attached to the fascia flap was sutured with Ethilon 6-0 
into the defect with the titanium facing the tracheal lumen. The skin of the neck region 
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was closed in three layers, the skin of the thorax was closed in one layer using Vicryl 
2-0.  
 
Group IV:  porous titanium exclusively. 
A full-thickness defect (through cartilage and mucosa) measuring 20 X 5 mm was 
created in the anterior cricoid and the first three tracheal rings. The defect was one-
third of the total circumference. A concave shaped titanium plate of 20 X 5 mm was 
sutured with Ethilon 6-0 to the defect. The skin was closed in three layers.  
Figure 6.4 shows the four groups in a schematic overview.  
 
Figure 6.5. Group I: porous titanium initially implanted on a vascularized fascia and combined 
with buccal mucosal graft (first stage) before transposing to the neck area (second stage). A) 
Laryngotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. The titanium is 
covered with a thin layer of mucosa (black arrows). B) Histological cross-section through the trachea 
(H&E). The arrow point indicates the opening in the posterior plane. The white arrow indicates the 
pedicled fascia. Note the integration of the titanium, which provides a concave tracheal lumen. The 
black arrow is pointing at the integration area, with some granulation tissue on the mucosa visible. C) 
Magnification (H&E, original x100,) of the integration area between the native tracheal mucosa and the 
mucosal graft. There is a thin mucosal layer visible covering the titanium (black arrows) (see page 121 
for color figures).  
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Macroscopic evaluation. After 6 weeks, the rabbits were killed with an overdose of 
pentobarbital and the laryngotracheal complex was dissected. Before termination, 
Groups I, II, and III underwent injection of the lateral thoracic artery with blue Microfil 
silicon dye (Canton Bio-Medical Products Inc., Boulder, Colo.) to assess the degree 
of revascularisation of the porous titanium and the mucosal graft component. The 
trachea was opened posteriorly in a vertical line and photographed. The trachea was 
then embedded in plastic for histological analysis.  
The reconstructed defects were evaluated in terms of mucosal covering over the 
titanium, presence of granulation tissue formation (signs of inflammation) between 
the titanium and native trachea, presence of titanium displacement and the 
connection between the titanium and cartilage.  
Microscopic evaluation. All reconstructed laryngotracheal complexes were fixed in 
formaldehyde and embedded in plastic and sections of 50 µm in thickness were 
made using a diamond saw (Leica SP1600; Leica AG, Glattbrugg, Switzerland) and 
stained with hematoxylin and eosin to evaluate integration of the graft and the 
surrounding tissues as well as vascularisation and viability of the mucosa. The 
mucosa was defined as vital when a normal pseudostratified ciliated columnar 
epithelium was identified with a basement membrane and a submucosal layer. 
 
Results 
Group I: porous titanium initially implanted on a vascularized fascia and 
combined with buccal mucosal graft (first stage) before transposing to the 
neck area (second stage). 
The first three rabbits survived the two operations until the end of the experiment, 6 
weeks after tracheal reconstruction. In two rabbits the titanium was covered with 
mucosa and the airway lumen was open (Figure 6.5A). Granulation tissue was seen 
in one of the suture sides in one rabbit. The third rabbit became dyspnoeic at the end 
of the experiment. On dissection of the cricotracheal complex, a segment of the 
titanium was noted to have shifted into the lumen of the trachea.  Because of this we 
decided not to operate on the other three rabbits. 
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Histological evaluation of the mucosa and the titanium showed revascularisation of 
the mucosa through the titanium, and a vital mucosa with normal aspects covering 
the titanium. In one rabbit some granulation tissue was found around a suture as 
noted on macroscopic inspection (Figure 6.5B); otherwise, no signs of inflammation 
or foreign body reaction were visible. The constructs were well integrated with the 
adjacent cartilage and soft tissues (Figure 6.5C).  
 
 
Figure 6.6. Group II: porous titanium implanted on a vascularized fascia (first stage) and 
combined with a buccal mucosal graft (second stage). A) Laryngotracheal complex of the rabbit 
after 6 weeks, cut open in the posterior plane. The titanium is covered with a thin layer of mucosa. 
Notice the dark color of the Microfil injection (circled) showing revascularisation of the cervical trachea. 
B) Histological cross-section through the trachea (H&E). The arrow point indicates the opening in the 
posterior plane. The white arrow indicates the pedicled fascia. Note the integration of the titanium, 
which provides a concave tracheal lumen. The black arrow is pointing at the integration area, with 
some granulation visible on top of the mucosa. C) Magnification (H&E, original x100) of the integration 
area between the native tracheal mucosa and the mucosal graft. There are clear mucosal and 
submucosal layers visible, covering the titanium. D) Magnification (H&E, original x400) of the 
integration area between the native tracheal mucosa (black arrows) and the buccal mucosal graft 
(arrow points) (see page 123 for color figures). 
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Group II: porous titanium implanted on a vascularized fascia (first stage) and 
combined with a buccal mucosal graft (second stage). 
The first three rabbits survived the experiment. In the second three rabbits, one rabbit 
was found dead after 3 days. On autopsy, the titanium was found to have been 
dislodged outside the tracheal lumen. Another rabbit was taken out of the experiment 
because of dyspnea and failure to eat. In this rabbit the titanium was found to have 
been dislodged into the lumen of the trachea. In one rabbit the titanium was slightly 
displaced into the lumen. The titanium was covered with mucosa. In two rabbits there 
was some granulation tissue around the sutures between the titanium and native 
trachea (Figure 6.6B and C). The mucosa was revascularized, as demonstrated on 
histology (Figure 6.6B and C) and confirmed by blue Microfil injection (Figure 6.6A). 
Figureure 6.6D shows an enlargement of the integration area with the buccal mucosa 
and the tracheal mucosa (Figure 6.6D). No differences were seen between the 
original mucosa of the trachea and the transplanted buccal mucosa (Figure 6.6D).  
 
Group III: porous titanium with vascularized fascia (single stage procedure). 
All six rabbits survived until the end of the experiment. The porous titanium was well 
integrated with the native tracheal cartilage and was fully covered with tracheal 
mucosa in five of the reconstructed defects. Blue Microfil injection showed 
revascularisation of the cervical trachea and the reconstructed defects (Figure 6.7A 
and C). 
Histological evaluation of the reconstructed defects showed fully revascularized 
titanium with pores filled with fibrous tissues and blood vessels (Figure 6.7B and D). 
Re-epithelialization of the porous titanium from the native trachea resulted in vital 
looking mucosa and submucosal layer (Figure 6.7E). In one of the reconstructed 
defects, the titanium was not connected to the cartilage and showed granulation 
tissue as signs of inflammation around the titanium. 
 
Group IV: porous titanium exclusively. 
All six rabbits survived until the end of the experiment. The porous titanium in all 
reconstructed defects was well integrated with the native tracheal cartilage and was 
fully covered with tracheal mucosa. There were neither granulation tissue formations 
nor signs of titanium displacement observed (Figure 6.8A and B).  
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Figure 6.7. Group III: porous titanium with vascularized fascia (single stage procedure). A) 
Laryngotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. The titanium is 
covered with a thin layer of mucosa. Notice the dark color of the Microfil injection (circled) showing 
revascularisation of the cervical trachea. B) Histological cross-section through the trachea (H&E). The 
arrow point indicates the opening in the posterior plane. The white arrow indicates the pedicled fascia. 
Note the integration of the titanium, which provides a concave tracheal lumen (black arrows). C) 
Magnification (H&E, original x100) of the pores in the titanium. Notice the presence of the blue Microfil 
filling the pores of the titanium. The black arrow is pointing to a bloodvessel with blue Microfil. D) 
Magnification (H&E, original x100) of the normal mucosal layer. The picture was taken in the area of 
the original incision (black arrow). Notice the stitch just submucosally (arrow point). E) Magnification 
(H&E, original x400) of the integration area between the cartilage and titanium. Notice a tight 
connection is present between the titanium and the cartilage (black arrow). There are clear mucosal 
and submucosal layers visible, covering the titanium (white arrow) (see page 125 for color figures).  
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Histological evaluation of the reconstructed defects showed fully revascularized 
titanium with pores filled with fibrous tissues and blood vessels (Figure 6.8C and D). 
The porous titanium was re-epithelialized from the native trachea with vital looking 
mucosa and submucosal layer (Figure 6.8D).  
 
 
Figure 6.8. Group IV: porous titanium exclusively. A) Laryngotracheal complex of the rabbit after 6 
weeks, cut open in the posterior plane. The titanium is visible under the mucosa. The titanium is 
covered with a thin layer of mucosa. B) Histological cross-section through the trachea (H&E). The 
arrow point indicates the opening in the posterior plane. Note the integration of the titanium, which 
provides a concave tracheal lumen. A clear mucosal layer covers the titanium (black arrows). C) 
Magnification (H&E, original x100) of the pores in the titanium. Notice the presence of fibrous tissue 
filling the pores of the titanium (black arrows). D) Magnification (H&E, original x200) showing vital 
mucosa covering the titanium (black arrows) (see page 127 for color figures). 
 
Discussion 
The optimal repair tissue for laryngotracheal reconstruction having three basic 
components, i.e. structural support, mucosal lining, and a vascular supply, does not 
exist clinically. We need tissue-engineering techniques, prefabrication techniques 
and the use of biomaterials to replace one or more of these components14. Structural 
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support to keep the airway open can easily be provided by a biomaterial. The 
biomaterial should allow repair of the mucosal lining, a prerequisite for clinical 
success. To obtain mucosal regeneration, the biomaterial should allow sufficient 
vascular supply. Our study demonstrated that laryngotracheal defects can be 
reconstructed with a porous titanium plate in combination with a vascular carrier and 
mucosal grafts. Porous titanium was previously used in rats by Schulz et al.15, who 
implanted porous titanium in total tracheal defects in 17 rats. Six rats died, five of 
them because of displacement or sealing of the prosthesis. 
Porous titanium combined with a mucosal graft and attached to a pedicled fascia flap 
can be a good alternative for tracheal reconstruction. This confirmed our previous 
study13. Titanium is sturdy enough to keep the tracheal lumen open and the porous 
matrix offers the opportunity for blood vessels to grow into the scaffold to 
revascularize the mucosal graft component. The pedicled fascia flap, on the other 
hand, provides for definite blood supply for revascularisation of the mucosa through 
the titanium.  
However, is a pedicled fascia flap really necessary to cause re-epithelialization? Or is 
an additional mucosa (or an epithelial equivalent) graft required to cover the defect? 
In groups I and II we used autologous mucosa. In group I, the mucosa was left to 
grow on a piece of titanium over the fascia for 2 weeks. An important drawback of 
buccal mucosa is the contamination with mouth flora. This leads to the development 
of granulation tissue as an inflammatory or infectious reaction. In group I, some 
granulation tissue was found around the stitches. Within group II, some granulations 
were noticed in two rabbits and two other rabbits succumbed, one due to a titanium 
implant dislodged outside the tracheal lumen and the other also due to an early 
dislodged titanium implant. Infection and granulation formation are the limitations, 
and these problems are frequently cited by other authors. This leads to obstruction of 
the lumen, air leakage or re-stenosis16. A possible solution could be the use of some 
sort epithelial equivalent, as described by Duff et al.17, who used cultured abdominal 
skin punches with collagen type II in a gel for re-epithelialization of a circumferential 
mucosal defect. 
In group III, we only used a pedicled fascia flap and yet the titanium was covered with 
mucosa in all six rabbits, demonstrating that re-epithelialization occurs from the 
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wound edges. In group IV we used titanium alone, which was covered with mucosa in 
all six rabbits. An important point to consider is the size limits of the tracheal defect 
that requires a pedicled fascia flap to speed up the process of revascularisation. The 
tracheal defects created in this experiment, which corresponds to about one-third of 
the total tracheal circumference can be reconstructed with titanium alone. The 
titanium was covered with mucosa after 6 weeks. For this kind of defects in a rabbit’s 
laryngotracheal complex, a vascular carrier and mucosal graft are not necessary. 
However, it is probable that bigger defects or circumferential defects require some 
assistance for their re-epithelialization, as regeneration from the wound edges might 
be insufficient. Shi et al.18 created a 45 mm long circumferential tracheal defect in 
dogs and reconstructed it with different types of prosthesis; they found re-
epithelialization only near the anastomotic ends. Delaere et al.11 found 
remucosalization of cartilage tubes for segmental tracheal defect only in the area of 
the anastomosis with a maximum of 3 mm. The question on the size limit of the 
defect that needs a vascular carrier and/or a mucosal graft is not answered by our 
study. 
Extrapolating these experiments to humans, it might be concluded that in healthy 
patients and for a small defect, titanium alone might be sufficient. However, patients 
with fibrosis of the neck area due to prior radiation treatment or previous operations 
probably need a vascular carrier to ensure the process of re-epithelialization from the 
wound edges. Larger defects also need a mucosal graft or patches of mucosa that 
could speed up the process of re-epithelialization. Another possibility is the use of 
tissue-engineered mucosa that can be added to the porous titanium, as shown by 
Rakhorst et al.19. 
We did not observe large differences between groups I and II, and III and IV, in terms 
of mucosal covering of the titanium, although we did observe problems in groups I 
and II with infection, granulation and titanium displacements.  
Another problem we encountered is the way of fixation the titanium. We used Ethilon, 
four stitches, one at each corner. In most of our rabbits the titanium was well 
integrated (groups III and IV), although some displacement of titanium into or outside 
the tracheal lumen was noticed in three rabbits (groups I and II). Fixation of the graft 
needs further attention, as this was the cause of death of two rabbits in group II. 
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Using more stitches might prevent collapse but carries the risk of more granulation 
tissue. Another solution could be the use of an overlay piece of titanium which is fixed 
outside the trachea and thus cannot collapse inside the lumen.  
To our knowledge, this is the first study that made use of porous titanium in a 
cricotracheal defect in combination with mucosal grafts and a pedicled fascia flap.  
 
Conclusion  
Our experiments demonstrate that reconstruction of a rabbit’s tracheal defect using 
composites of porous titanium, mucosal grafts and a fascia flap is feasible. However, 
it is still a long way before this kind of composite grafts may be used in clinical 
practice, especially if larger and circular defects have to be reconstructed. 
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Chapter 7 
 
Summary and general discussion 
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This thesis deals with some of the problems of laryngotracheal stenosis (LTS). More 
specifically, it deals with those patients who need laryngotracheal reconstruction after 
partial resection for benign or malignant tumours, trauma or re-stenosis of the 
laryngotracheal complex. 
 
Laryngotracheal stenosis 
LTS is a growing problem in the field of otorhinolaryngology. Due to improved 
extensive surgery and better intensive care units, more patients are intubated and 
require ventilation for extended periods of time. There are many different approaches 
to treat stenosis, each with its own benefits and disadvantages. The choice for a 
specific surgical procedure depends on factors such as severity, exact location and 
overall length of the stenosis. For severe subglottic (grade II, III and IV according to 
Myer-Cotton scale1) and short segment stenosis, the generally accepted surgical 
procedures of choice are the the cricotracheal split with cartilage interposition grafts 
or cricotracheal resection (CTR) followed by end-to-end anastomosis.  
 
Single Stage Laryngo Tracheal Reconstruction (SS-LTR). Single Stage 
laryngotracheal reconstruction as we described in chapter 2 is a technique in which 
the stenosis is expanded after anterior and posterior split. In the past, this technique 
involved placement of intraluminal stents for an extended period of time. At present 
stenting in SS-LTR procedures would only involve the temporary use of an 
endotracheal tube2,3. CTR on the other hand is a technique in which the stenotic 
segment is removed and the trachea is anastomosed to the subglottic space. CTR is 
only possible with some subglottic tissue left to suture the trachea. SS-LTR is in our 
opinion the treatment of choice for grade II and III stenosis without residual subglottic 
space. CTR on the other hand is indicated for cases of severe subgottic stenosis with 
enough subglottic space (grade III and IV). In chapter 2 we describe 60 patients who 
underwent a SS-LTR procedure at the Sophia children’s hospital in the period 
January 1994 until December 2006. Fifty-seven patients of the 60 (95%) had a 
sufficient laryngeal lumen at the time of discharge. This was defined as a situation 
when the patient could breathe normally without any stridor at rest. Initially, only nine 
patients (15%) were re-intubated. This decanulation rate of 95% is comparable with 
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the decanulation rates found in literature after SS-LTR or CTR4-7. Cotton et al. 
reported 86% successful results for SS-LTR in their study in 19928 and  mentioned a 
decanulation rate of 90% for all techniques used9. Triglia et al.10 reported 95% 
decanulation rate in 98 children who were operated on with different techniques 
including 58 laryngotracheal reconstructions. In our series, patients were extubated 
as soon as possible with a median duration of intubation of 4 days. Patients 
extubated after 2 days (two patients) and after 3 days (seven patients) also did well. 
One patient who extubated himself accidentally 1 day after the operation, was not re-
intubated and recovered well. This suggests that it is possible to limit the duration of 
intubation to less than 4 days. The idea of using a tube as a kind of ‘’stenting’’ does 
not seem to be necessary with this technique. One can imagine that the longer the 
tube stays in place, the greater the chance of tissue trauma and thereby impeding 
the process of remucosalization. SS-LTR should be considered a feasible one-stage 
and safe operation in selective cases of LTS in children. Our series suggest that 
intubation time after the operation should be as short as possible.  
 
Cartilage imaging. In chapter 3 we focused on the cartilage grafts used in 
laryngotracheal reconstruction. Imaging of cartilage of the larynx with MRI is not yet 
extensively described in the pediatric literature. MRI of articular cartilage is standard 
care for diagnosis of articular disorders. MRI of tracheal cartilage grafts in rabbits was 
previously showed by Delaere et al.11 in 1999 with high resolution gadolinium 
enhanced T1-weighted spin echo sequence. We used different MRI techniques with 
special surface coils to give a high resolution of the cricotracheal complex and 
thereby making the cartilage more visible. In three patients from our series described 
in chapter 2, we performed a MRI 3, 6 and 11.5 years respectively after the initial 
operation. All grafts were visible even after 11.5 years. There was no cartilage-to-
cartilage connection but the cartilage grafts were in place and connected to their 
surrounding with fibrous (scar–like) tissue. No signs of resorption were seen even 
11.5 years after implantation. The conclusion seems justified that autologous 
cartilage with perichondrium will not resorb in time. One possible explanation is that 
perichondrium provides the cartilage with nutrients. Another possible explanation 
could be that perichondrium prevents infection of the cartilage and thereby 
resorption. Zalzal et al.12 used autologous costal cartilage in rabbits for reconstruction 
of an anterior split. In the perichondrium group (32 rabbits) no infection was seen. In 
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the group without perichondrium (15 rabbits) four had infection. Cartilage grafts can 
be visualized with a MRI-technique using a special surface coil and thin slices based 
on a gradient echo technique as we described. This can be useful in follow-up of 
patients in which cartilage grafts are implanted. 
 
Laryngotracheal defects 
Surgical repair of the cricotracheal complex in long segment stenosis involving more 
than half of the entire tracheal length and re-stenosis after an initial resection and 
end-to-end anastomosis, require some kind of reconstruction. Other patients who 
need a reconstruction are patients after major trauma, or after resection of a benign 
or malignant tumour. These kinds of reconstructions remain a therapeutic problem 
since further resection of the trachea is usually not possible. 
Many investigators attempted to create a neo-trachea with cartilage and mucosa. 
There are some clinical case reports in which a neo-trachea was formed using 
autologous costal cartilage or seeded chondrocytes in a marlex mesh tube with 
palatal mucosal graft13,14. All patients survived these procedures, but the 
disadvantage was the need for staged surgery, which is necessary to create the neo-
trachea. Herberhold et al. described a series of 112 patients in which preserved 
allografts from donors were used for tracheal reconstruction in long segment 
stenosis15. However, at present many are reluctant to use homografts because of the 
Creutzfeld Jacob’s disease and other possible infections. It is therefore not 
considered the first choice of therapy. Recently, Machhianrini et al.16 described a 
clinical case where they used a homograft trachea bioengineered with autologous 
stem cells with success. 
Optimal tissue for tracheal reconstruction should contain three different components, 
i.e. a support tissue to keep the lumen open, a good epithelial lining, preferably 
consisting of mucosa, and a vascular supply17. Ideally, a tissue for laryngotracheal 
reconstruction would consist of viable cartilage and respiratory mucosal lining similar 
to that of the native trachea. 
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Cartilage integration. In chapter 4 we focused on cartilage-cartilage integration. 
Cartilage integration is hindered by a lack of matrix producing cells in the interface 
region. This is mainly caused by chondrocyte death and the inability of chondrocytes 
to migrate through the extracellular matrix towards the lesion edges, where 
integrative repair capacity is required. In previous studies, we treated cartilage with 
highly purified collagenase which provides vital matrix-producing cells near the 
cutting surface. This was shown to improve integrative cartilage repair18. In this 
chapter, we demonstrated that cartilage integration can be achieved by treating for 
only one hour using a combination of highly purified collagenase and hyaluronidase. 
It appeared to be possible to add these two enzymes simultaneously, facilitating 
clinical application. Furthermore, in an in vivo integration experiment where only the 
inner core (graft) was enzyme-treated, we showed aside to this increase in vital cell 
numbers, more frequent integration of the extracellular matrix with matrix fibers 
crossing over from the enzyme-treated part to the untreated part.  
The increase in amount of cells is accompanied by improved integration. In our in 
vivo integration experiment we saw that 80% of the constructs was integrated 
(defined by connection between core and outer ring over more than 5% of the 
interface area), whereas in the control group 46% of the constructs showed 
integration. We demonstrated that short enzymatic treatment with a combination of 
hyaluronidase and collagenase increases the amount of vital chondrocytes in wound 
edges and has a positive effect on integrative cartilage repair. The integration 
experiment showed (new) fibers crossing over from enzyme treated cartilage to the 
untreated part. This suggests that enzyme treatment will be favourable for integrative 
cartilage repair. By reducing the treatment time from 48 hours to 1 hour and treating 
the graft only, we are a step closer to the possible clinical application of this 
procedure.  
In addition to the cartilage that should form a suitable support tissue, the trachea 
should also have a good epithelial lining preferably consisting of respiratory mucosa 
and a vascular supply to support the mucosa. Unfortunately there is no such 
composite tissue elsewhere in the body that can meet all these requirements. Most of 
the reconstructive tissues applied clinically lack one or both components leading to 
the large variation in results. Using tissue-engineering techniques, Delaere et al.17 
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created a prefabricated and prelaminated repair tissue composed of revascularized 
elastic ear cartilage with buccal mucosal lining and applied it clinically with 
satisfactory results. A major drawback of this technique is the long waiting period that 
is necessary to allow revascularisation of the mucosa and remucosalization of the 
cartilage graft, before the whole regenerated tissue can be finally transferred to the 
neck area. Cartilage, by nature is avascular and possesses anti-angiogenic 
properties, making it a less suitable support tissue for mucosal grafts. This was 
clearly shown by Delaere and Hardillo19, when they reconstructed circumferential 
tracheal defects in rabbits with tubed auricular cartilage pre-wrapped in vascularized 
fascia. Despite the improvement of vascularisation around the tube, healing through 
remucosalization only occurred around the anastomotic regions leaving the central 
portions of the grafts bare and partially necrotic. 
 
Biomaterials. To improve reconstruction of the trachea, several experimental 
approaches have been taken with animal models, such as autologous cartilage with 
laryngotracheal frameworks from solid titanium, Medpor or hydroxyapatite20,21, tissue-
engineered cartilage with chondrocytes seeded in polypropylene or polyglycolic acid 
with or without mucosal lining22-24 and prefabricated tubes with cartilage strips and a 
vascularized muscle or fascia25. They all had the same problem, that is, the 
restoration of the mucosal lining through re-epithelialization. This occurred from the 
wound edges in small defects but for larger defects this process of re-epithelialization 
proved to be insufficient. The key to the problem might be speeding up the process of 
revascularisation. This can be achieved with the use of porous materials, in which 
new vessels can grow through the pores to reach the epithelializing surface to 
revascularize an implanted mucosal component and thereby ensure its survival. The 
biomaterial of choice should be strong enough to keep the airway lumen open, and 
the material should not evoke a foreign body reaction or inflammation. These 
requirements are met by titanium. Titanium is a material that has been used for years 
as an implantation material in both orthopedics and maxillofacial reconstructive 
surgery. Titanium is chemically resistant to the corrosive and oxidative activities of 
various agents26. It has also been shown to be very well tolerated by animal and 
human tissues making it a suitable material for tracheal reconstruction. 
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Mucosal survival on porous titanium. In chapter 5 we investigated the mucosal 
survival on porous titanium before using it in a rabbit model. This study used porous 
titanium in combination with mucosal grafts and clearly showed histological evidence 
of revascularisation of the mucosal graft. After 1 week, new blood vessels were 
observed growing from the underlying tissue through the titanium scaffold. The 
presence of the Neuro-Patch eliminated possible revascularisation of the mucosa 
from the surrounding tissues other than the back muscle. The importance of this 
revascularisation was also highlighted by the observation that the mucosal grafts in 
combination with cartilage grafts appeared non vital. We demonstrated that titanium 
is sturdy enough to keep the lumen open and the porous matrix offers the opportunity 
for blood vessels to grow into the scaffold. This allows re-epithelialization and survival 
of a mucosal graft. Titanium has been described to be an ideal biomaterial in a septic 
environment like the trachea and our rabbit study confirmed this. No inflammatory 
response or foreign body reactions were observed after 6 weeks of implantation. 
 
Reconstruction with porous titanium. In chapter 6 we reconstructed a full-thickness 
laryngotracheal defect using porous titanium in four different ways in an animal model 
to see if a pedicled fascia flap is really necessary to cause re-epithelialization and to 
see if an additional mucosa (or an epithelial equivalent) graft is required to cover the 
defect. In groups I and II we used autologous mucosa. In group I we used a buccal 
mucosal graft combined with porous titanium implanted on a vascularized fascia flap 
(first stage) before transposing to the neck area (second stage). In group II porous 
titanium was implanted on a vascularized fascia flap(first stage) and then transposed 
to the neck area and combined with a buccal mucosal graft (second stage). An 
important drawback of buccal mucosa is the contamination with mouth flora. This 
leads to formation of granulation tissue as an inflammatory reaction. We found 
granulation tissue around the stitches in both groups I and II. In group II, two rabbits 
succumbed due to dislodged titanium. Infection and granulation formation are the 
limitations and problems also frequently cited by other authors. This leads to 
obstruction of the lumen, air leakage or re-stenosis27.  
In group III and IV we did not use buccal mucosa and we saw no granulation tissue 
and infections in these groups. In group III, we only used a pedicled fascia flap with 
titanium in a one-stage operation and yet the titanium was covered with mucosa in all 
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six rabbits, demonstrating that re-epithelialization occurs successfully from the wound 
edges. In the last group we only used titanium which was covered with mucosa in all 
six rabbits at the moment of sacrifice.  
These results lead to the question if it is really necessary to use a flap and a mucosa 
graft. Defects that we created (20 X 5 mm in the anterior cricoid and the first three 
tracheal rings) which corresponded to about one-third of the total cricotracheal 
circumference can be reconstructed with single titanium as shown in group IV. The 
titanium was covered with mucosa after 6 weeks even in the absence of a definite 
vascular carrier. We should consider which defect’s size needs a pedicled fascia flap 
to speed up the process of revascularisation. Bigger defects or circumferential 
defects require some assistance for their re-epithelialization, as the regeneration from 
its wound edges might be insufficient. Shi et al. created a 45 mm long circumferential 
tracheal defect in dogs and reconstructed it with different types of prosthesis. They 
found re-epithelialization only near the anastomotic ends28. Delaere et al.19 found 
remucosalization of cartilage tubes for segmental tracheal defect only on the site of 
the anastomosis with a maximum of 3 mm. Extrapolating these experiments to 
humans it might be concluded that in healthy patients and for a small defect (less 
than one-third in tracheal circumference and involving less than three tracheal rings) 
single titanium is sufficient. However, for those patients with fibrosis within the neck 
area due to prior radiation treatment or previous operations, a definite vascular 
carrier in the form of a pedicled or free vascularized flap might be needed to ensure 
the process of re-epithelialization from the wound edges. Larger defects (more than 
one-third in circumference and more than three tracheal rings) probably would also 
need a mucosal graft or patches of mucosa that could speed up the process of re-
epithelialization.  
One problem that we encountered, particularly in groups I and II is the presence of 
infection and granulation tissue formation which could have been brought about by 
the introduction of buccal mucosa contaminated with mouth flora. This problem can 
be minimized by using tissue-engineered mucosa in future experiments. 
Another problem we encountered is the fixation of the titanium to the native tachea. 
We used Ethilon sutures, with one stitch at each corner to fix the titanium to the 
trachea. Using more stitches might prevent collapse but carries the risk of more 
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granulation tissue. In most of our rabbits the titanium was well integrated (group III 
and IV) although some displacement of titanium into or outside the tracheal lumen 
was noticed in three rabbits (group I and II). Fixation of the graft needs further 
optimization. More stitches could be used. Another possibility is the use of an overlay 
technique in which the titanium is fixated outside the trachea and therefore cannot 
collapse inside the lumen. 
 
Conclusion and future perspectives 
Surgical intervention in LTS is a challenging aspect in the otorhinolaryngology work 
field. With the growing incidence of intubated patients, different techniques have 
been developed and still are being developed. The initial goal of these surgical 
interventions was decanulation and normal breathing but the goals have expanded to 
include better voice quality, less invasive techniques and less time in hospital. For 
SS-LTR we tried to keep the intubation time as short as possible with high success 
rates.  
With modern MRI techniques it is possible to visualize cartilage, even in the young 
child. This can be useful in the follow up of operated patients with a cartilage graft 
and gives us a better understanding of the survival of cartilage grafts in time and the 
integration of the graft with its surrounding. This can be important because a lot of 
children are operated on a young age and with growth the cricoid and larynx will 
change with the years.  
Cartilage integration can be stimulated by enzymatic treatment. At this time this 
enzymatic treatment is only used in experimental settings. More studies need to be 
undertaken to bring back the treatment period to an acceptable time for clinical use. 
One could think that if this enzyme treatment could be used in laryngotracheal 
reconstruction, for instance as an enzymatic tissue glue, a better connection is 
formed between the trachea and the cartilage graft.  
For the larger cricotracheal defects that have to be reconstructed, three components 
are necessary as we mentioned; a support tissue to keep the lumen open, a good 
epithelial lining and a vascular supply. We think that porous titanium is a promising 
biomaterial which is sturdy enough and allows revascularisation of mucosa through 
the pores. A fascia or muscle flap provides the necessary vascularisation of the 
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mucosal grafts. The problem however of fixation of the titanium safely and 
permanently on the cartilage of the laryngotracheal structure of the host needs further 
study.  
The problem with infection when using buccal mucosal grafts could be solved by 
adding antibiotics or by using cultured mucosa harvested in more sterile conditions 
as mucosal lining. This has been already studied in different ways. Duff et al.29 used 
cultured abdominal skin punches with collagen type II in a gel for re-epithelialization 
of a circumferential created mucosal defect in dogs. They saw severe stenosis 
(>95%) in the control group and mild stenosis (<20%) for the treated group. 
In this thesis we combined in vitro, in vivo and clinical experiments in LTS and 
reconstruction. For stenosis in children good long-term results of SS-LTR have been 
demonstrated, making it an excellent technique for most of the patients. With the 
cartilage studies we performed we have made a step forward in optimal cartilage 
integration. The imaging of cartilage grafts with MRI will allow us to better evaluate 
our operation techniques and the survival of cartilage grafts in time. For patients with 
large defects we are positive about the use of porous titanium which can be 
combined with mucosal grafts and vascular carries.  
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Dit proefschrift handelt over de problematiek van vernauwingen van het strottenhoofd 
en de luchtpijp, beter bekend als laryngotracheale stenoses. Meer in het bijzonder 
deden wij onderzoek naar patiënten die een laryngotracheale reconstructie moesten 
ondergaan na bijvoorbeeld partiele resectie voor een goed of kwaadaardige tumor, 
trauma of re-stenose van het laryngotracheale complex. 
 
Laryngotracheale stenose 
Stenose van het laryngotracheale complex is een toenemend probleem in de keel-, 
neus- en oorheelkunde. Door verbeterde operatietechnieken en betere intensive care 
units, worden meer patiënten geïntubeerd en beademend. Een mogelijke complicatie 
hierbij is vorming van een stenose. Er bestaan verschillende manieren om zo’n 
stenose te behandelen, elk met eigen voor- en nadelen. De keuze voor een 
specifieke chirurgische ingreep hangt af van een aantal factoren te weten: graad van 
de stenose, exacte locatie en lengte van de stenose. Voor uitgebreide stenose van 
het gebied direct onder het strottenhoofd, de subglottische stenose (graad II, III en IV 
volgens de Myer-Cotton schaal) en voor een korte segment stenose is de algemeen 
geaccepteerde operatietechniek het klieven van het cricotracheale segment, gevolgd 
door interpostitie met kraakbeen, dan wel cricotracheale resectie en end-to-end 
anastomose  
 
In hoofdstuk 2 beschrijven we het laryngotracheale herstel, in het Engels de Single 
Stage Laryngo Tracheal Reconstruction (SS-LTR), bij kinderen. SS-LTR is een 
techniek waarbij de stenose wordt gespleten aan de voor- en achterkant waarna de 
beide helften uit elkaar worden geschoven. Vroeger werd er hierna een stent 
geplaatst voor langere perioden. Tegenwoordig wordt bij een SS-LTR geen gebruik 
meer gemaakt van een stent. Het enige ‘’stenten’’ is teruggebracht tot het gebruik 
van een endolaryngeale tube voor een duur die in dagen kan worden geteld. Onze 
studie liet zien dat deze duur van de intubatie kan worden teruggebracht tot slechts 
een paar dagen. 
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In hoofdstuk 3 hebben we het lot onderzocht van de kraakbeenstukjes (grafts) die 
gebruikt zijn bij SS-LTR. Verschillende MRI technieken met speciale coils geven een 
hoge resolutie van het cricotracheale complex waarmee het kraakbeen beter 
zichtbaar kan worden gemaakt. Bij drie patiënten uit onze serie beschreven in 
hoofdstuk 2, werd een MRI gedaan 3, 6 and 11,5 jaar na de initiële operatie. Alle 
grafts waren goed zichtbaar, zelfs na 11,5 jaar. Er was geen integratie van de beide 
ingebrachte kraakbeenstukken met het oorspronkelijke kraakbeenskelet maar de 
kraakbeen grafts waren met hun omgeving vergroeid doormiddel van littekenweefsel 
(fibreus weefsel). Er werden geen tekenen van resorptie gezien. Concluderend 
resorbeert autoloog kraakbeen met perichondrium niet met de tijd en kan het 
zichtbaar gemaakt worden met een speciale MRI techniek. Dit kan bruikbaar zijn in 
de follow-up van patiënten na gebruik van kraakbeen grafts in laryngotracheale 
reconstructie. 
 
Laryngotracheale defecten 
Chirurgisch herstel is noodzakelijk van een verwijderd cricotracheaal complex dat 
een lengte heeft van meer dan de helft van die van de trachea, en restenose na 
eerdere end-to-end anastomose. Andere patiënten die een reconstructie nodig 
hebben zijn patiënten na een groot trauma of na een resectie van een goed- of 
kwaadaardige tumor. Deze reconstructies blijven een probleem omdat er niet genoeg 
weefsel meer over is om te gebruiken voor herstel van het verwijderde gedeelte. 
Er is al veel onderzoek gedaan naar reconstructie methoden voor de trachea en 
larynx. Optimaal weefsel zou uit drie verschillende componenten moeten bestaan, te 
weten: een ondersteunend weefsel om het lumen open te houden, een goede 
slijmvlies bekleding aan de zijde van het lumen van de luchtweg en goed doorbloed 
weefsel dat het geheel voldoende kan voeden. Bij voorkeur zou men moeten kunnen 
beschikken over kraakbeen-met-luchtwegslijmvlies voor dit soort reconstructies. 
 
In hoofdstuk 4 onderzochten we de kraakbeen-kraakbeen integratie. 
Kraakbeenintegratie wordt gehinderd door een gebrek aan matrix producerende 
cellen in het gebied van de contactvlakken (interface). Dit is hoofdzakelijk het gevolg 
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van chondrocyten necrose en de onmogelijkheid van chondrocyten om door de 
extracellulaire matrix heen te migreren naar de interface regio waar zij nodig zijn voor 
het herstel. In dit hoofdstuk toonden we aan dat kraakbeenintegratie verbetert als het 
kraakbeen gedurende 1 uur behandeld wordt met een combinatie van de enzymen 
collagenase en hyaluronidase. In een in vivo integratie experiment zagen we meer 
vitale chondrocyten, betere integratie en extracellulaire matrixvezels die van het ene 
stuk kraakbeen naar het andere overgingen. Een goede kraakbeenintegratie is van 
belang voor de mechanische integriteit van de structuur en voor de groei van de 
structuur als het een kind betreft. 
De luchtpijp heeft ook een goede binnenbekleding nodig. Met gebruik van tissue-
engineering technieken is in het verleden een geprefabriceerde samenstelling van 
gerevasculariseerde stukjes oorkraakbeen en wangslijmvlies met een fascie-lap 
gemaakt om een defect in de luchtweg te reconstrueren. Het grote nadeel van deze 
techniek is de lange tijd die het slijmvlies nodig heeft om te revasculariseren. 
Kraakbeen bevat van nature geen bloedvaten en daardoor zullen er geen bloedvaten 
door het kraakbeen heen kunnen groeien naar het slijmvlies.  
Met het gebruik van poreus materiaal is het wel mogelijk om bloedvaten vanuit de 
diepere lagen naar het slijmvlies te brengen voor de bloedvatvoorziening 
(vascularisatie). Dat biomateriaal moet stevig genoeg zijn om de luchtweg open te 
houden en moet door de omgeving goed verdragen worden zonder dat het een 
immuunreactie of een infectie opwekt. Deze eigenschappen heeft poreus titanium 
allemaal. Titanium is een materiaal dat al jaren voor implantatie wordt gebruikt in de 
orthopedie en kaakchirurgie. Titanium is chemisch resistent tegen corrosieve oxidatie 
van verschillende stoffen. Het wordt ook zeer goed getolereerd in zowel humaan als 
dierlijk weefsel waardoor het een geschikt materiaal is voor tracheale reconstructie. 
 
In hoofdstuk 5 onderzochten we de overleving van slijmvlies op poreus titanium. In 
een athymische muis werd aan de ene kant op de rugspieren een stukje titanium met 
wangslijmvlies geplaatst en aan de andere kant een stukje oorkraakbeen met 
slijmvlies. Al na een week, werden er nieuwe bloedvaten gezien komende van de 
onderlaag en groeiend door het titanium richting het slijmvlies. Bovendien werd er op 
het titanium vitaal slijmvlies waargenomen. Op het kraakbeen was het slijmvlies 
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necrotisch. We toonden in een levend konijn aan dat titanium stevig genoeg is om de 
luchtweg open te houden en dat er nieuwe bloedvaten door het titanium heen 
groeien, waardoor het slijmvlies vanuit de wondranden beter en sneller over het 
titanium kan regenereren. Er werden geen ontsteking of afweerreacties gezien. 
 
In hoofdstuk 6 reconstrueerden we full-thickness laryngotracheale defecten in 
konijnen met een combinatie van poreus titanium, slijmvlies en een gesteelde fascie-
lap. Het doel was te kijken of een fascie-lap en slijmvlies transplantaat eigenlijk wel 
nodig zijn voor een defect en of titanium alleen ook kan volstaan. In groep I 
gebruikten we een wangslijmvliestransplantaat gecombineerd met  poreus titanium 
geïmplanteerd op een gevasculariseerde fascie-lap (eerste operatie) voordat we het 
geheel naar de hals transporteerden (tweede operatie) voor het herstel. In groep II 
werd voor de reconstructie gebruik gemaakt van poreus titanium dat geïmplanteerd 
werd op een gevasculariseerde fascie-lap (eerste operatie) en daarna verplaatst naar 
de hals, samen met een wangslijmvliestranplantaat (tweede operatie).  
In deze twee groepen zagen we veel granulatie weefsel als uiting van ontsteking, 
waarschijnlijk vanuit en door het wangslijmvlies. In groep III en IV hebben we geen 
slijmvlies gebruikt. In groep III, hebben we poreus titanium gebruikt met een facie-lap 
in een enkele operatie. In groep IV hebben we alleen poreus titanium gebruikt. In 
deze groepen hadden we geen problemen met ontsteking en granulatievorming. 
Deze resultaten laten zien dat voor de defecten die wij gecreëerd hebben (20 X 5 
mm in het anterieure cricoid en de eerste drie trachea ringen) uitsluitend titanium 
voldoende is zoals we zagen in groep IV. Waarschijnlijk is voor grotere defecten of 
voor circulaire defecten titanium alleen niet voldoende. De vraag is vanaf welke 
grootte van het defect een slijmvliestransplantaat en/of extra bloedvoorziening wel 
nodig is  
Een ander probleem dat nog opgelost moet worden is de fixatie van het titanium. Wij 
fixeerden met vier hechtingen maar in twee konijnen in groep II was het titanium naar 
binnen losgeschoten. Meer hechtingen of toepassing van een soort ‘’overlay’’ 
techniek van het titanium kunnen dit mogelijk voorkomen. 
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Conclusies  
Chirurgische interventie in laryngotracheale stenose vormt een uitdaging binnen de 
keel-, neus- en oorheelkunde. Er zijn verschillende herstelmogelijkheden waarbij de 
SS-LTR een techniek is met goede resultaten. 
Met moderne MRI technieken is het mogelijk om kraakbeen zichtbaar te maken, ook 
in een jonger kind. Dit kan nuttig zijn voor evaluatie van laryngotracheale 
reconstructies waarbij kraakbeengrafts werden gebruikt. Het kraakbeen resorbeert 
niet, zelfs niet op lange termijn. 
Kraakbeen-kraakbeen integratie kan gestimuleerd worden door enzymbehandeling. 
Meer onderzoek moet gedaan worden om de klinische toepasbaarheid te testen. 
Hierbij kan gedacht worden aan ontwikkeling van een soort enzymlijm die 
bijvoorbeeld bij de SS-LTR toegepast kan worden voor een betere 
kraakbeenintegratie waardoor de mechanische integriteit en de vorm van het 
kraakbeenskelet beter is. 
Voor grote cricotracheale defecten zijn drie componenten nodig voor een geslaagde 
reconstructie. We denken dat poreus titanium in combinatie met slijmvlies en een 
vorm van bloedvoorziening een goed alternatief zou kunnen zijn voor de grotere 
defecten. Problemen die nog overwonnen moeten worden zijn de kans op infectie bij 
slijmvlies grafts en de fixatie van het titanium in zijn omgeving. 
In dit proefschift hebben we in vitro en in vivo laboratoriumstudies gecombineerd met 
klinische studies met als doel vernauwingen en defecten van de luchtweg en het 
strottenhoofd door middel van reconstructieve technieken te behandelen. In de 
toekomst zullen echter nog verdere verbeteringen moeten worden aangebracht. 
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Color figures 
 
  
Figure 1.2. Cross-section of human trachea (H & E). A) Magnification, (original x10) with submucosa 
and respiratory epithelium. B) Magnification, (original x40) shows the different layers of the epithelium 
and cartilage. 
 
 
4.6A 4.6B
4.6C 
4.3 
Figure 4.6. Zone of the enzyme treated cartilage in integration experiment. A) Chondrocyte density at 
the interface of treated inner core (right) and untreated outer ring (left; H&E, original x100). Integration 
area (arrows) shows almost 100% integration. B, C) Magnification of the integration area (H&E, 
original x400). B) More vital chondrocytes are visible in the enzyme-treated inner core (left) in 
comparison with untreated outer ring of the cartilage (right). C) collagen fibers are crossing over from 
the treated part (bottom) to untreated part (top). 
Figure 4.3. Chondrocyte death in the wound edges (H&E, original x100). Fourteen days after 
wounding acellular band is visible at wound edge (circled). Left is the superficial layer and right is deep 
layer. 
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Figure 5.1. A) Titanium plate of 10 X 10 X 2 mm. with pores ranging from 400 to 700 ųm and a 
porosity of 90%. B) Magnification of Figure A (original x10). 
 
 
A B
Figure 5.3. Histological section of human buccal mucosa on top of titanium after 2 weeks of 
implantation. A) Human buccal mucosa (H&E original x2.5). The black material is titanium. The 
mucosa is attached to the titanium. The pores of the titanium are filled with fibrous tissue and blood 
vessels. The white arrows point to the basal layer of the mucosa. B) Magnification (H&E original x10) 
showing the titanium filled with fibrous tissue and blood vessels (white arrows). 
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Figure 5.4. Rabbit buccal mucosa. A) Rabbit buccal mucosa on top of titanium (H&E magnification 
original x25). Note the intact basal layer as indicated by the black arrows. B) Rabbit buccal mucosa on 
top of ear cartilage (H&E magnification original x25). In the middle of the picture the cartilage is visible 
with its chondrocytes (black arrows). There is no connection between the mucosa and the cartilage. 
The basal layer of the mucosa is not visible (white arrows). 
 
 
5.2 5.5
Figure 5.2. The back of an athymic mouse with on the left a cartilage piece with rabbit’s buccal 
mucosa. On the right, a titanium plate with rabbit’s buccal mucosa. This is post termination after 2 
weeks of implantation. 
Figure 5.5. Cytokeratin staining (CK13) on rabbits buccal mucosa after 2 weeks of implantation with a 
clear basal membrane (black arrows) and suprabasal keratinocytes of vital mucosa (original 
magnification x100, visualization with New Fuchsin, counterstain with Gill’s haematoxylin). 
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Figure 5.6. Cricotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. A) The 
titanium is visible under the mucosa with stitches (black arrows). The titanium is covered with a thin 
layer of mucosa. B) Histological cross-section through the trachea (H&E). The short black arrow 
indicates the opening in the posterior plane. The white arrow indicates the pedicled fascia. Note the 
integration of the titanium, which provides a concave tracheal lumen. A thin layer of mucosa is 
covering the titanium. Some granulation tissue is present on the left side of the titanium just inside the 
tracheal lumen (long black arrow). C) The pores in the titanium (H&E, original magnification x200). 
Notice the presence of fibrous tissue filling the pores of the titanium. The black arrow is pointing at a 
bloodvessel. D) The integration area between the cartilage and titanium (H&E original magnification 
(x100). Notice a tight connection is present between the titanium and the cartilage (black arrow). 
 
  
Figure 6.3. Schematic drawing of a rabbit with the titanium plate placed on the left lateral thoracic 
fascia flap.  
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Figure 6.1. Curved titanium plate of 20 X 5 mm and a thickness of 2 mm, with pores in the range 400-
700 ųm and a porosity of 90%. 
 
 
Figure 6.5. Group I: porous titanium initially implanted on a vascularized fascia and combined 
with buccal mucosal graft (first stage) before transposing to the neck area (second stage). A) 
Laryngotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. The titanium is 
covered with a thin layer of mucosa (black arrows). B) Histological cross-section through the trachea 
(H&E). The arrow point indicates the opening in the posterior plane. The white arrow indicates the 
pedicled fascia. Note the integration of the titanium, which provides a concave tracheal lumen. The 
black arrow is pointing at the integration area, with some granulation tissue on the mucosa visible. C) 
Magnification (H&E, original x100,) of the integration area between the native tracheal mucosa and the 
mucosal graft. There is a thin mucosal layer visible covering the titanium (black arrows).  
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Figure 6.6. Group II: porous titanium implanted on a vascularized fascia (first stage) and 
combined with a buccal mucosal graft (second stage). A) Laryngotracheal complex of the rabbit 
after 6 weeks, cut open in the posterior plane. The titanium is covered with a thin layer of mucosa. 
Notice the dark color of the Microfil injection (circled) showing revascularisation of the cervical trachea. 
B) Histological cross-section through the trachea (H&E). The arrow point indicates the opening in the 
posterior plane. The white arrow indicates the pedicled fascia. Note the integration of the titanium, 
which provides a concave tracheal lumen. The black arrow is pointing at the integration area, with 
some granulation visible on top of the mucosa. C) Magnification (H&E, original x100) of the integration 
area between the native tracheal mucosa and the mucosal graft. There are clear mucosal and 
submucosal layers visible, covering the titanium. D) Magnification (H&E, original x400) of the 
integration area between the native tracheal mucosa (black arrows) and the buccal mucosal graft 
(arrow points). 
 
 
Figure 6.4. Schematic drawing of the four different groups. Groups I and II are operated on using a 
two-stage procedure; groups III and IV are operated on using a one-stage procedure. 
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Figure 6.7. Group III: porous titanium with vascularized fascia (single stage procedure). A) 
Laryngotracheal complex of the rabbit after 6 weeks, cut open in the posterior plane. The titanium is 
covered with a thin layer of mucosa. Notice the dark color of the Microfil injection (circled) showing 
revascularisation of the cervical trachea. B) Histological cross-section through the trachea (H&E). The 
arrow point indicates the opening in the posterior plane. The white arrow indicates the pedicled fascia. 
Note the integration of the titanium, which provides a concave tracheal lumen (black arrows). C) 
Magnification (H&E, original x100) of the pores in the titanium. Notice the presence of the blue Microfil 
filling the pores of the titanium. The black arrow is pointing to a bloodvessel with blue Microfil. D) 
Magnification (H&E, original x100) of the normal mucosal layer. The picture was taken in the area of 
the original incision (black arrow). Notice the stitch just submucosally (arrow point). E) Magnification 
(H&E, original x400) of the integration area between the cartilage and titanium. Notice a tight 
connection is present between the titanium and the cartilage (black arrow). There are clear mucosal 
and submucosal layers visible, covering the titanium (white arrow).  
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Figure 6.8. Group IV: porous titanium exclusively. A) Laryngotracheal complex of the rabbit after 6 
weeks, cut open in the posterior plane. The titanium is visible under the mucosa. The titanium is 
covered with a thin layer of mucosa. B) Histological cross-section through the trachea (H&E). The 
arrow point indicates the opening in the posterior plane. Note the integration of the titanium, which 
provides a concave tracheal lumen. A clear mucosal layer covers the titanium (black arrows). C) 
Magnification (H&E, original x100) of the pores in the titanium. Notice the presence of fibrous tissue 
filling the pores of the titanium (black arrows). D) Magnification (H&E, original x200) showing vital 
mucosa covering the titanium (black arrows). 
 
 
Figure 6.2. Cervical area of the rabbit exposed (A) before and (B) after creation of the full-thickness 
defect (through cartilage and mucosa) measuring 20 X 5 mm in the anterior cricoid and the first three 
tracheal rings. The defect is one-third of the total circumference. The head is downwards in this image. 
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